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 Previous investigators demonstrated that epididymal white adipose tissue (EWAT) 
lipectomy suppressed spermatogenesis and caused atrophy of the seminiferous tubules.  EWAT 
lipectomy, however, may disrupt testicular innervation, which reportedly compromises testicular 
function.  To resolve this confound and better clarify the role of EWAT in spermatogenesis, 
three experimental groups of hamsters were created in which:  i.) the superior and inferior 
spermatic nerves were transected (SSNx) at the testicular level, ii.)  EWAT was extirpated 
(EWATx), and iii.)  testicular nerves and EWAT were left intact (SHAM controls).  It was 
hypothesized that transection of the superior and inferior spermatic nerves would disrupt normal 
spermatogenesis.  The findings indicate a significant reduction in spermatogenic activity and 
marked seminal tubule atrophy within the EWATx testis, as compared to the SSNx and controls 
testes, which did not differ significantly from each other.  From these data, it is concluded that 
EWAT, and not testicular innervation, is central to normal spermatogenesis.  
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I. Overview and Background  
 
 The kinetics of spermatogenesis.  The cellular events which involve the mitotic 
differentiation of spermatogonia into spermatocytes, followed by the meiotic differentiation of 
these spermatocytes into the immature, non-motile spermatids is called spermatogenesis, 
whereas the transformation of the spermatids into mature, motile spermatozoa (=sperm) is called 
spermiogenesis (1-4).  In mammals, spermiogenesis involves between 16-19 distinct, 
morphological stages, which occur in the epithelia of the seminiferous (seminal or germinal) 
tubules (2, 5, 6).  In the present review, however, the two processes—spermatogenesis and 
spermiogenesis—are regarded as a singular, yet multistep biologic process, and the former term 
is adopted for ease of discussion.  In studying the histopathological effects of a particular agent 
or a surgical treatment on spermatogenesis, Russell (2) suggests a thorough understanding of the 
kinetics of spermatogenesis under normal physiological conditions. Thus, the following 
discussion concerns the origins of the various types of spermatogonia and the development of 
these germ cells into primary spermatocytes.   
 Traditionally, two major groups of spermatogonia—Type A and B—have been classified 
on the basis of several morphological features, including organization of the rough endoplasmic 
reticulum (RER), stainability (e.g., dark vs. pale), chromatin grain (e.g., coarse vs. fine) and 
distribution within the nucleus (7, 8).  The classification of spermatogonia by these criteria is 
quite often complex and difficult, while identification of the spermatogonia by the latter criterion 
is commonly obscured by poor fixation techniques.  Technical advances in election microscopy 
have aided in the identification of three morphological subtypes of Type A spermatogonia, which 
have been characterized in higher mammals, including primates and rodents (9-12).  The task of 
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identifying the Type A subtypes, however, is in itself complicated by the different 
spermatogonial naming systems, which vary somewhat from author to author (2, 13).  The 
publication by Russell et al. (2) provides  micrographs and detailed descriptions of each subtype,  
and consequently, the spermatogonial nomenclature  used by Russell will be used for the 
remainder of this report. 
 The first spermatogonial subtype are the dark-staining Type A (Ad) spermatogonia, 
which are mitotically quiescent in the post-pubertal testis (14),  yet proliferate in an 
gonadotrophin-independent fashion in the infant and juvenile testis of the Rhesus monkey (8).   
Thus, in the pre-pubertal testis, the Ad cells act as proliferative stem cells, which have the 
limitless ability to self-renew and produce committed progenitor cells (CPCs; 15, 16, 17) , 
whereas, in the normal adult, Ad cells serve as reserve (dormant) stem cells (7, 18).  Despite 
divergence in the scientific community regarding the definition of the CPC, which has persisted 
over the past decade, Kalthoff (19) explains that the CPC is a undifferentiated cell type, which—
restricted in its development—can only differentiate into a specific cell type. 
 Arising from the Ad cells, the progenitor Ap cells, the second subtype, undergoes several 
amplifying (mitotic) divisions to produce identical clones, which are linked by cytoplasmic 
bridges formed by incomplete cytokinesis (2).  The cytoplasmic bridges represent intercellular 
connections which allow for the transfer of biomolecules between adjacent/attached germ cells, 
thereby mediating the synchronized development of the spermatogonial clones within the 
synctial chain (2, 19).   The third subtype type —the transitional Type A (At) spermatogonia—
which exhibit features intermediate to that of the Ad and Ap spermatogonia,  are only visualized 
when Ad and Ap cells are present during the fetal period, 3-4 years preceding the appearance of 
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Type B spermatogonia (11).  It is generally accepted the At subtype is not an intermediate form 
between Types A and B spermatogonia (12).   
 Once the Ap cells cease to divide, the Ap clones typically differentiate (through at least 
four cell types denoted Ap1-Ap4) into Type B spermatogonia (2, 14, 18, 20, 21).  However, one 
study suggested that Ap spermatogonia may also generate Ad and At spermatogonia during each 
successive division (12).  In this model, Ap spermatogonia behave as renewing stem cells to 
ensure continuation of spermatogenesis, while giving rise to Type B progenitor cells at puberty.  
To complete this first half of spermatogenesis, Type B cells differentiate into diploid primary 
spermatocytes, which  subsequently enter meiosis to produce haploid secondary spermatocytes 
(21). 
 According to Russell et al. (2), fully differentiated spermatogonia are committed to 
becoming mature spermatozoa, unless germinal degeneration occurs during some part of their 
development.  Degeneration, which is similar to program cell death (or apoptosis) in somatic 
cells, is a normal and constant phenomenon of the developing germ cells during spermatogenesis 
(22-24).  Although the cause and purpose of degeneration are poorly understood, it has been 
suggested that degeneration maintains an optimal or ideal Ap- and/or germ-to-Sertoli cell ratio 
(25).  In this way, when deviations from ideal conditions persist, the ratio may act as a critical 
limiting factor which triggers degeneration (25).   According to estimates, only one-fourth of the 
theoretically possible number of primary (preleptotene) spermatocytes, which arise from fully 
differentiated Type B cells, are produced from the original population of Ap1 spermatogonia 
(25).   Consequently, the actual yield of sperm is consistently much lower than what can be 
predicted by the spermatogonial and spermatocytes division kinetics alone (2, 3).    
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 The rate of germ cell degeneration is accelerated in pathogenic states.  Germ cell 
degeneration is observed most often in the differentiating Ap2 and Ap3 cells, during meiosis (i.e., 
primary and secondary spermatocytes), and in stages 7 and 19 of spermiogenesis in normal adult 
male rats (24, 25) and stallion (26).  Similarly, Huckins (25) reported that degeneration occurs 
less often in the Ap4 cell type and rarely in the Ap1 and Type B spermatogonia.  Histological 
hallmarks of degeneration first appear once the Ap clones, which are linked cytoplasmic bridges, 
complete DNA synthesis (S phase) and enter the second growth (G2) phase of the cell cycle (25).  
Degeneration is characterized by an increase stainability of the nuclear envelope, karyorrhexis 
(literally, ―nuclear fragmentation‖), and pyknosis, which is shrinkage and clumping of the 
nuclear chromatin— the latter two phenomena mediated by an arsenal of apoptotic-promoting 
molecules (25, 27).  The nuclear mass is eventually extruded from the cell, ―leaving a 
cytoplasmic ghost‖ (25).   The chronological steps in degeneration can be traced from one cell to 
its sister clones, suggesting that the apoptotic effectors synthesized within one cell may spread 
via cytoplasmic bridges to eventually affect all spermatogonia within the synctial chain (2, 25).  
Multinucleated germ cells (MGC), which are conspicuous markers of spermatogenic disorder 
and germ cell degeneration, are formed when the plasma membranes of adjacent spermatocytes 
(or round spermatids) coalesce during the latter stages of spermiogenesis (2, 28, 29).  The 
subsequently widening of the cytoplasmic bridges leads to fusion of the cellular contents and 
formation of these unusually large cells, which are released into the seminal lumen where they 
will eventually degenerate (28, 29).   
 Numerous studies in laboratory rat demonstrated that degeneration can be initiated by 
environmental conditions, including:  i.) deficiency of an essential nutrient, such as vitamin A, a 
retinoid critical for normal cell differentiation and stem cell biology (30-33) or ii.)  exogenous 
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administration of pharmacologically-active agents, such as ethionine, a non-proteinogenic amino 
acid (34), nitrofurazone, an antibiotic (35),  or methylmercury, a highly toxic bioaccumulent 
(36).  Endogenous substances, such as nitric oxide (NO; 37), steroidal hormones (26, 38-40), and 
prolactin (PRL; MW 22 kDa; 41)  have been linked to germ cell degeneration in higher 
vertebrates, especially when these substances are present at above normal physiological levels.  
Lastly, a wide range of specific and non-specific insults to the reproductive tract and testis—
which include transection of the testicular nerve supply (42, 43), vasectomy (44-48),  changes in 
testicular temperature (26, 38, 49, 50),  prolonged lead or cadmium exposure (2, 26, 51),  
infectious disease (26, 51),  and dietary deficiencies (52, 53)—increase the rate of degeneration 
of the developing germ cells, which dramatically reduce the spermatogenic yield. 
 Stages of spermatogenesis and in the cycle.  There are distinct morphological features of 
the spermatocytes and spermatids that distinguish the last ten spermatogenic stages of the rat 
from the first nine stages.  These include the shape of the acrosome, level of nuclear 
condensation, flagellum status, status of the mitotic spindle, mitochondrial arrangement and the 
distribution and amount of cytoplasm (2, 5, 6, 54).  Clermont et al. (55) described the cyclic 
transformations in the epithelial architecture, which represent characteristic spatial and temporal 
transformations in the organization and combination of the germ cells during spermatogenesis.   
The duration of this cycle of the seminiferous epithelium (or simply, the cycle), which consists 
of 6 to 14 stages—denoted by Roman numerals to prevent confusion with the stages of 
spermatogenesis—varies greatly between the mammalian species,  and even among the various 
strains of animals of the same species (2, 20, 55, 56).  Interestingly, a study involving the 
autoradiographic labeling of testicular tissue from incarnated, human volunteers demonstrated 
that the cycle in humans consists of 6 stages, which occurs over a 16-day period, while the entire 
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spermatogenic process spans 64 days (57).   For these data, one can infer that spermatogenesis in 
man requires 4 cycles of the germinal epithelium (2).  A quantitative assessment by Hess (56) 
revealed statistical differences in the spermatid (nuclear) shape and diameter, distance of the 
acrosomal tip from the basal lamina and frequency of mitosis between the various stages in the 
cycle over time.  Additionally,  Hess (56) includes a dichotomous key, which can be used to 
qualitatively classify the various stages of the cycle, while Hess et al. (58) proposed group size 
and sampling guidelines for evaluating alterations in the frequency of stages in the cycle as a 
indication of the effects of a particular [testicular] treatment on spermatogenesis.    
 Anatomy and physiology of the male reproductive tract.  As previously mentioned, 
spermatogenesis is especially sensitive to changes in temperature (59, 60, reviewed in 61).  
Consequently, the testes are positioned outside the body in a sack of skin called the scrotum, 
which maintains the testes at an optimal temperature 2°C  and 8°C below body temperature in 
man (52, 62, 63) and murine (64), respectively.  Contraction of the cremaster and dartos smooth 
muscles of the scrotum affect the compensatory re-positioning of the testes in response to 
changes in environmental and body temperature (63).   Testicular temperature is also maintained 
by modifying the rate of perfusion to the testis, which is mediated by autonomic neural control of 
the testicular vasculature (38, 59, 61, 65-67). 
 The glandular testis is encapsulated by the white, thick tunica albuginea (Fig. 1a-b), 
which is itself covered by the tunica vaginalis (not depicted in illustration), except at the junction 
of the epididymis and testis alongside the posterior border, and where the spermatic blood 
vessels enter the testis (63).  The interior of the testis proper is subdivided into approximately 
250 lobules,  which each contain one to three highly-convoluted,  seminiferous tubules that 
constitute the bulk of the testicular mass (68).   Along with the Leydig cells, whose functions 
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will be discussed later, the testicular macrophages, fibroblasts, Sertoli cells, and peritubular 
myeloid cells (PMC) represent the somatic cell lines of the testis.  The Leydig cells and testicular 
macrophages account for 25% of the cells in the interstitium of the testis (2, 69), the latter cell 
entering the germinal space only under severe pathological  states to phagocytize nonviable cells 
and cellular debris (70).  Although similar to the resident macrophage populations of other 
tissues, the testicular macrophages are not as immunologically potent as other macrophages, yet 
these cells secrete cytokines, lysozymes and present antigens (70, 71).  The fibroblasts, also of 
the testicular interstitium, maintain the extracellular matrix (ECM) and provide attachment for 
the investing vasculature, which include blood vessels and the lymphatics (2).   
 The large, columnar Sertoli cells, which span from the basal lamina of the tubule wall to 
the adluminal surface, provide developmental support for the germ cells; the PMCs surround the 
entire seminiferous tubule (2, 19, 72).  Tight junctions between adjacent Sertoli cells form the 
blood-testis barrier, creating two compartments:  i.) an exterior compartment of premeiotic 
spermatogonia and ii.)  an interior compartment of postmeiotic spermatocytes, spermatids, and 
spermatozoa within the seminal tubule (2, 19, 21).  During the process of spermiation, 
cytoplasmic bridges between adjacent sperm are broken and sperm emerge tail first into the 
seminal lumen (or central cavity) of the seminal tubule (2, 73).  Spermatozoa not released during 
spermiation, as well as apoptotic germ cells and discarded cytoplasmic contents (i.e., residual 
bodies) are phagocytized by the Sertoli cells (2, 74).  Next, sperm are temporarily stored in the 
lumen before entering into a network of 30 short collecting tubules called the straight 
seminiferous tubules (2, 75).  The straight tubules converge at the rete testis (Fig. 1c), which is a 
reticular space located in the medial to the testis proper, yet on the posterior pole of the testis (63, 
76, 77).   
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 The sperm exit the rete testis in the efferent ducts to enter the caput (head) epididymis 
(Fig 1), thence the corpus (body) epididymis, and lastly, the cells traverse into the cauda (tail) 
epididymis where the sperm will mature (i.e., become motile and acquire the ability to fertilize 
78).  The testis is bound tightly to the proximal end of the caput epididymis via the superior 
ligament of the testis (SL; Fig. 1a-b), where the tunica vaginalis is thickened into a dense 
network of connective fibers.  The inferior ligament of the testis (IL), which is contiguous with a 
portion of the scrotal wall, connects the cauda epididymis to the inferior pole  of the testis (Fig. 
1a-b) and is characterized by a thick bundle of connective strands (79).   During ejaculation, a 
two-stage event that begins with seminal emission, where the sperm are expelled from the cauda 
epididymis and enter the muscular vas deferens (Fig 1b), is followed by the ejaculation proper, 
where rhythmic contractions of the vas deferens propel the sperm through the remaining portions 
of the male reproductive tract, which include the ejaculatory duct, urethra, and the glans penis 
(62, 63, 77, 80, 81).  Before exiting the body, the sperm are bathed in milky secretions from the 
seminal vesicles, bulbourethral and prostate glands (Fig. 2), which provide nourishment for the 











FIGURE 1:  ULTRASTRUCTURE OF THE HUMAN TESTIS.  Exterior surface of the 
testis (a) and in cross section (b and c).
1
   
 (a) Epididymis (1);   Caput epididymis; region of superior ligament (2);  Lobules of 
epididymis (3);  Corpus epididymis (4);  Cauda epididymis ; region of interior ligament (5);  
Duct of epididymis (6);  Ductus deferens or vas deferens (7) 
 (b) Superior pole of testis (1);  Tunica albuginea (2); Testicular septa (3); 
Anterior/ventral margin (4);  Lateral surface (5); Inferior pole of testis (6); Testicular lobules (7); 
Parenchyma of testis (8);  Efferent ducts (9);  Mediastinum testis (10); Posterior/dorsal margin; 
region of testicular hilium (11) 
 (c)  Testicular septa (1); Seminiferous tubules (2);  Testicular lobules (3);  Straight 
seminiferous tubules (4);  Efferent ducts (5); Rete testis (6) 
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 The figure above is a faithful reproduction of an illustration created for educational purposes by the United States 
Federal Government.  Pursuant to Title 17, Chapter 1, Section 105 of the U.S. Code, original works of the United 









FIGURE 2: ACCESSORY ORGANS OF MALE REPRODUCTION.  Schematic of the 
accessory sex organs of man, in cross section.
2
     Vas deferens (1); Seminal vesicle (2); Base of 
the prostate (3); Apex of the prostate (4); and  Prostatic urethra (5)  
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 Endocrine and local factors control testicular function and androgenesis.  Endocrine 
control of the male gonads is accomplished primarily by two hormones— luteinizing hormone 
(LH) and follicle-stimulating hormone (FSH)—which are secreted by the gonadotrophs, a group 
of specialized cells in the pars distalis (PD) region of the adenohypophysis, called also the 
anterior pituitary gland (63, 82-85).  In addition to thyroid-stimulating hormone (TSH), also of 
the adenohypophysis,  and human chorionic gonadotrophin  (hCG),  which is secreted by the 
placental syncytiotrophoblasts (86),  LH and FSH are members of a small, yet functionally 
diverse, family of proteins called the glycoproteins (83, 87, 88).  The glycoproteins are 
composed of monomeric α and β subunits, which are linked by disulfide bridges at several amino 
acid positions (reviewed in 88).  Oligosaccharide side chains are covalently bonded to the amide 
nitrogen of asparagine (Asn) residues on one or more of the subunits (83, 89, 90).  In humans, 
the amino acid sequences of the α subunits of LH and FSH are identical— both hormones have a 
total of 204 amino acids and a MW of ~30kDa (83, 87, 91).  According to a review by Ryan et 
al. (83),  the ultrastructural characteristics of the glycoproteins are highly conserved across 
several vertebrate species, which is evident in the high sequence homology of each subunit.  
Sugar moieties at positions α-56 and α-82 are also conserved in the structures of LH and FSH 
throughout the mammalian taxon (83, 87, 89, 90, 92-94).  Conversely, the variable nature of the 
β subunit confers distinct immunological responses, differential receptor binding capabilities, 
and unique pharmacological properties, which ultimately contribute to the highly-specific 
biological actions of the glycoprotein hormones (83, 87).   
 The gonadotrophins act in synergy to mediate androgen (male sex hormone) 
production/secretion and spermatogenesis, which are the two principle functions of the 
mammalian testis (85, 91).  The synthesis and subsequent secretion of LH and FSH is governed 
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by gonadotrophin-releasing hormone (GnRH), a decapeptide neurohormone released from the 
anterior medial peptic area of the hypothalamus (91, 95, 96).  In both males and females, 
secretion of GnRH is cyclical, occurring in episodic bursts every 90 minutes (91, 95).  In males, 
the hypothalamopituitary-gonadal axis is regulated by a negative-feedback control mechanism 
with the actions of the sex hormones and inhibin, a testicular endocrine factor, serving to 
downregulate secretion of GnRH and the gonadotrophins (85, 91, 95).   
 LH and testicular steroidogenesis.  Luteinizing hormone binds to the extracellular 
domains of the LH receptor (LH-R), a member of the G-protein coupled receptor (GPCR) family 
located on the surface of the interstitial Leydig cells (69, 97-99).  Activation of the LH-R 
initiates an intracellular signaling transduction cascade mediated by the cyclic AMP (cAMP) 
second messenger system and the lipophilic prostaglandins (100).   The phosphorylation of 
downstream signaling elements by cAMP activates transcriptional expression of the 
steroidogenic acute regulatory protein (StAR; MW 30 kDa), which transports cholesterol 
(C27H46O) to the P450 side-chain cleavage enzyme complex (P450scc) of the inner 
mitochondrial membrane (101-104).  As the name implies, P450scc catalyzes the cleavage of the 
nonpolar side chain at the C-17 position of the cholesterol molecule which results in the 
production of pregnenolone (105).  The side-chain cleavage reaction is the rate-limiting step in 
the de novo synthesis of the steroid hormones (98, 105, 106).  Hydroxylation of pregnenolone 
produces 17-OH pregnenolone, which is subsequently converted to the prohormone 
dehydroepiandrosterone (DHEA), the primary precursor to the gonadal steroids in both sexes 
(91).  Despite being a weak androgen, DHEA is a potent neurosteroid agonist of the sigma-1 
receptor of the central nervous system (CNS; 91, 107, 108, 109).  Reduction of DHEA by the 
enzyme 3β-hydroxysteroid dehydrogenase generates androstenedione, which is subsequently 
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reduced to testosterone (T) by the enzyme 3β-hydroxysteroid dehydrogenase (91, 110).   It is 
worth noting here that the zona reticularis of the adrenal cortex is a secondary site for 
steroidogenesis, synthesizing  <5% of the weak androgens in circulation (91).   
 There exist several reports of an intimate physiologic association between the testicular 
macrophages and male reproductive function, wherein the testicular macrophages influence 
steroidogenesis and modulate the responsiveness of the Leydig cell to LH (70, 111).  Microvilli 
on the Leydig cell surface, which interdigitate with the coated pits or vesicles on the surface of 
the testicular macrophage, mediate the crosstalk between the two cells (111).  In mice deficient 
for the gene encoding colony-stimulating factor-1 (CSF1-KO), the main growth factor for 
macrophage development within the reproductive tract, Cohen et al. (111) reported that mutants 
displayed low sperm number, decreased libido, and significantly reduced plasma T and LH 
concentrations as compared to wild-type males. Others investigators report that Leydig cells 
grown in media, which was previously exposed to testicular macrophages, secrete more T than 
control Leydig cells (70).  The testicular macrophages secrete 25-hydroxycholesterol (25-HDC), 
an oxysterol (oxidized form of cholesterol) with myriad biologic functions.  At micromolar 
concentrations,  25-HDC induces apoptosis of lymphocytes and is cytotoxic to tumor cells (112),  
however this oxysterol also mediates the differentiation of hepatocytes (113), keratinocytes 
(113), and promotes the development of Leydig cells in utero (70), and after birth (114).  In the 
absence of cholesterol, 25-HDC is an excellent substrate for steroidogenesis by circumventing 
the StAR protein transport system of the Leydig cell (115).  These independent observations 
suggest a central role that the testicular macrophages have in promoting the morphological 
development of the testis and in mediating Leydig cell physiology.  
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  After secretion from the Leydig cell, DHEA, androstenedione, and T enter into systemic 
circulation where they are taken up by cellular targets in adipose tissue, CNS, bone, and the 
reproductive tract (91).  Inside the target tissues, DHEA and androstenedione may bind to 
intercellular the androgen receptors (AR), members of the nuclear receptor superfamily which 
are similar in function to the progesterone and estrogen receptors (PR and E2R, respectively; 116, 
117-119).  Activation of the AR leads to expression of various gene products that mediate lipid 
and carbohydrate metabolism, protein synthesis, muscle development, bone growth and 
maturation in nonreproductive tissue (120-122)  as well as the promotion of spermatogenesis in 
the male reproductive tract (119, 123-126).  Androgen receptors also have ―nongenomic‖ 
functions,  including the  promotion of vascular function and induction of second messengers 
signaling systems (91, 116). 
 Alternatively, once inside of target tissues, DHEA and androstenedione can be converted 
into T, which, in turn, is reduced to 5α-dihydrotestosterone (DHT) by the enzyme 5α-reductase 
within the prostate, testis, and adrenal cortex (91, 110).  During fetal development the in utero 
production of DHT, a powerful anabolic hormone  which has an AR binding affinity 3 times that 
of T, drives the development of the internal and external genitalia, whereas in puberty, DHT is 
responsible for the onset of the male secondary sex characteristics (91, 110).   Other successive 
metabolites of T include the testicular estrogens—specifically, estrone (E1) and estradiol (E2)—
which are produced in a well-characterized biochemical reaction involving the enzyme 
aromatase (ARO; reviewed recently 127, 128-130).     
 The role of estrogen in reproductive tract function (128, 130-132) and mediating 
copulatory behavior (133-136) in males is multifaceted and the focus of ongoing research.  
Previous studies in rat demonstrate that administration of estrogen, in combination with T, 
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lowers testicular weights and leads to reversible azoospermia (137), but did not affect male 
mating behavior (138) , serum concentrations of T and E2, and sex organ accessory weights 
(137).  Simultaneous administration of both steroids led to antagonistic effects, i.e., initial 
decreases in testicular function and accessory organ weight caused by estrogen treatment were 
countered by sufficient doses of T (137).  Robaire et al. (137) demonstrated that while low doses 
of estrogen, without added T, did not significantly affect serum E2 levels, testicular weights and 
spermatid or spermatozoa counts, estrogen treatment resulted in significant reductions in serum 
LH and testosterone levels and in the weights of sex accessory organs; no significant changes in 
FSH were detected in all treatment groups. Higher doses of E2, without administration of T, led 
to increased serum estradiol levels, and produced a sustained reduction in the testicular and sex 
accessory organ weights and testicular sperm count (137).  Subsequent researchers, using mice 
homozygous for a mutation in the E2R gene (E2R knockout or E2RKO), reported no visible 
anatomical aberrations in the prostate glands, epididymi, and seminal vesicles of E2RKO mice 
(139).  Mating studies demonstrated that the E2RKO animals were infertile, as compared to the 
heterozygous E2R mutants and wild-type animals that produced several offspring (139).  
Histological analysis of the seminiferous tubules of E2RKO mice revealed enlarged luminal 
diameters, whereas the seminal epithelia of other animals were disorganized or mainly filled with 
Sertoli cells (139).  In any case, spermatogenic cells were nearly absent in the seminal tubules of 
E2RKO mice, suggesting a novel role of E2R in mediating normal spermatogenesis (139).  
 The morphological integrity of the germinal epithelium is maintained by FSH.  The 
formation of tight junctions (=zonula occludens) between adjacent Sertoli cells, which 
completely envelope the developing germ cells, is stimulated by FSH.  The intimate association 
between the Sertoli and germ cells is the basis for the seminal epithelial architecture, which is a 
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characteristic feature of the healthy testis during the cycle (56).  FSH and T also increase the 
synthesis of inhibin and androgen-binding protein (ABP) when they are bound to the 
extracellular domains of the Sertoli cell FSH receptor (FSHR), also a GPCR (91).  Inhibin 
downregulates the secretion of GnRH and FSH, whereas ABP binds to T, DHT, and E2 to 
decrease the hydrophobicity of these hormones, an effect which consequently increases the 
solubility and concentration of these hormones within the luminal fluid of the seminiferous 
tubules, epididymis, and systemically (91).  In turn, the increased concentration of T and DHT 
promote spermatogenetic activity within the testis and the maturation of the spermatozoa within 
the cauda epididymis (76, 77, 81, 91).   
 According to the lumicrine hypothesis,  factors that are secreted by upstream cells can 
regulate the activities of downstream cells via a luminal or ductal network (81).  Support for this 
hypothesis  is reviewed by Hinton et al.(81), who cite studies where ligation of the efferent ducts 
resulted in apoptosis and morphological changes in the epithelial cells of the proximal 
epididymis, whereas expression and the activity of the epididymal genes proteins, respectively, 
are affected by loss of testicular factors secreted by the upstream Leydig and/or Sertoli cells.  
ABP is one such testicular factor that is widely considered to exert its affects on the epididymis.  
Studies suggest that APB regulates expression of 5α-reductase within the epithelial cells of the 
caput epididymis,  and thus the production and concentration of  DHT within the caput lumen 
(81).   As the initial point of sperm entry into the epididymis, the caput epididymis, under the 
influence of luminal factors, may play an important role in the maturation and development of 
the spermatozoa in more distal regions of the epididymis. 
 Gronning et al. performed in vivo experiments, which have further elucidated the actions 
of FSH on the Sertoli cell (140) .  The investigators showed that the expression of tissue inhibitor 
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of metalloproteinases-1 (TIMP-1) in whole testes was significantly reduced in 
hypophysectomized male rats, along with serum levels of FSH (140).  However, expression of 
TIMP-1 could be upregulated by exogenous administration of FSH in hypophysectomized males 
(140).  Northern blot analysis confirmed the presence of TIMP-1 within the nuclei of peritubular 
and Sertoli cells, whereas the nuclei of Leydig cells, primary spermatocytes, and spermatids were 
not immunoreactive (ir) for TIMP-1 (140).  TIMP-1 are the endogenous inhibitors to matrix 
metalloproteinases (MMPs),  enzymes that degrade extracellular matrix (ECM) proteins,  
mediate cell proliferation, differentiation, and apoptosis—all integral functions of normal 
physiological tissue remodeling (141).   These findings suggest that FSH, in regulating the 
expression of the endogenous inhibitors of MMPs, may also mediate tissue remodeling, which is 
critical for the germ cell rearrangements of testicular organogenesis and of the cycle (140).   
 The gonadotrophins also regulate the secretion of autocrine factors from the peritubular, 
Leydig, and Sertoli cells, which, in turn, govern the release of paracrine factors that mediate the 
development of undifferentiated spermatogonia, developing spermatocytes, and spermatozoa 
(142).  In summary, a plethora of autocrine and paracrine factors of gonadal origin have been 
identified (reviewed extensively in 72).  For example, the pro-inflammatory cytokines, which 
include:  i.) interleukin-1 alpha, interleukin-1 beta, and interleukin-6 (IL-1α, IL-1β, and IL-6, 
respectively), tumor necrosis factor alpha (TNF-α) and interferon gamma (IFN-γ), along with 
several growth factors including:  ii.)  leukemia inhibitory factor (LIF) and stem cell factor 
(SCF), mediate crosstalk between adjacent Sertoli cells (142, 143) and promote germ cell 
proliferation of the spermatogonia and development of the spermatocytes (144).  The Sertoli cell 
also secretes transferrin, ceruloplasmin, retinol-binding protein, which are likely to influence 
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germ cell development and the secretion of germ cell paracrine factors, such as nerve  and 
fibroblast growth factors which influence Sertoli cell physiology (21). 
 Recent empirical evidence indicates that members of the IL-1 family:   i.) increase Sertoli 
cell expression of testicular TIMP-1 (140), ii.)  increase the proliferation of immature Sertoli 
cells, even more so than FSH (145), and  iii.) increase the growth and differentiation of 
peritubular and Sertoli cells, while interacting with human growth hormone (GH; MW 22kDa) 
and insulin-like growth factor-I (IGF-I) to increase T secretion (146).  Finally, other groups have 
demonstrated that abnormally high levels of pro-inflammatory cytokines, a characteristic feature 
of prolonged diseased states, negativity affects spermatogenesis and androgen production (142, 
144).   
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II. Role of the autonomic nervous system in male reproductive function 
 
 Overview of the autonomic nervous system.  The autonomic nervous system (ANS) is 
organized into ganglia (sing. ganglion), which are dense aggregations of neuronal cell bodies 
scattered throughout the periphery, and represents all the nerve pathways that form ganglion 
synapses outside of the CNS (75, 147).  Neurons that synapse onto the peripheral ganglia are 
called preganglionic and have cell bodies in the brain or spinal cord (i.e., in the CNS), whereas 
neurons whose cell bodies are located within the peripheral ganglia are called postganglionic (75, 
147).  The ANS is divided into an efferent (motor) arm, which sends output various effectors, 
including  glands and muscles of the vasculature, viscera, and genitourinary tract, via the cranial 
nerves (III, VII, IX, and X) and spinal preganglionics (75, 147).  The afferent (sensory) arm 
receives information from the sense organs and viscera via the cranial nerves (VII, IX and X) 
and the general visceral afferent fibers (GVA; also called sympathetic afferent fibers; 75, 148).  
Traditionally, the motor arm of the ANS has been divided into three, distinct neuroanatomical 
divisions—the enteric, sympathetic and parasympathetic nervous systems (ENS, SNS and PSNS, 
respectively; 75).  The interneurons, efferent and afferent neurons of the ENS are found within 
two types of ganglia—Auerbach's (myenteric) and Meissner's (submucosal) plexuses—situated 
in the mucosa of the gastrointestinal (GI) tract (147).  Unlike the SNS and PSNS, which require 
input from the CNS to operate, the neurons of the ENS function autonomously, communicating 
with the CNS mainly by the parasympathetic vagus (X) nerve (75).   
 A general appreciation of the physiological features of the SNS and PSNS is essential to 
understanding the role of the ANS in mediating male reproductive function.  Thus, the following 
discussion, albeit brief, is warranted and serves to provide a basic framework in which to view 
the more detailed discussions of this report. 
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 Physiology of the autonomic nervous system.  The cell bodies of the SNS are found in the 
intermediolateral gray matter of the thoracolumbar spinal cord and exit the CNS via the ventral 
roots located at T1-L2 (148).  The preganglionic fibers of the SNS synapse onto postganglionics 
located in the 24 pairs of sympathetic (paravertebral) chain ganglia, which run on either side of 
the spinal cord (147).  The SNS preganglionics may also synapse onto the prevertebral ganglia, 
which include the inferior and superior mesenteric ganglion (IMG and SMG, respectively), 
celiac ganglion (CG), and aortic-renal ganglia—unpaired, midline ganglia situated anterior to the 
aorta and vertebral column (75, 148).  The  preganglionic fibers of the PSNS (or the craniosacral 
outflow as it is more commonly called) originate from several brain stem nuclei, including the 
dorsal motor nucleus (DMV) of the vagus nerve, which provide extensive neural input to the 
viscera and urogenital tract (147), and from the sacral spinal cord.  The sacral outflow exits via 
the lower three sacral roots (S2-S4) of the spinal cord to form the pelvic splanchnic nerve (PSN; 
known also as the nervi erigentes), which innervates the viscera and genitals (75, 149).   
 The actions of the SNS and PSNS, which are largely antagonistic to each other, are 
mediated by the release of the neurotransmitters acetylcholine (Ach) and norepinephrine (NE) 
from the pre- and postganglionic sympathetic neurons, respectively, and the release of Ach from 
all neurons of the PSNS (75).  Neurons which release Ach are called cholinergic, whereas nerves 
which release NE are called adrenergic or catecholaminergic (75).  It is also worth noting here 
that the adrenal medulla is widely considered a modified postganglionic sympathetic neuron, 
releasing the catecholamines NE and epinephrine (E) when stimulated by preganglionic neurons.  
The postganglionic neurons of the PSNS also release cotransmitters, such as vasoactive intestinal 
peptide (VIP) and neuropeptide Y (NPY), neuronal nitric oxide synthase (NOS), in addition to 
Ach (148).   
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 Not surprisingly, receptors which bind NE and E are called adrenergic receptors (ADR) 
and fall into two main groups—α and β—which are further subdivided into various 
morphophysiologically-distinct isoforms (reviewed in 150).  The two subtypes of the α-ADR 
family, which include α1ADR and α2ADR, are generally associated with mediating effector 
excitation (reviewed in 151).  Isoforms of α1 are α1AADR, α1BADR, and α1DADR, whereas α2 
exists as α2AADR, α2BADR, and α2CADR (reviewed recently in 147).  The intracellular domains 
of α1ADR receptor are linked to the heterotrimeric G protein (Gq), a member of the GPCR 
superfamily (91).   Activation of Gq via ligand binding to the extracellular domains of the α1ADR 
mediates the catalytic activity of phospholipase C (PLC), which cleaves phosphatidylinositol 
phosphate (PIP2), a membrane lipid, into inositol triphosphate (IP3) and diacylglycerol (DAG).  
Diffusion of IP3  into the cytoplasm mediates the release of calcium (Ca
2+
) from the ER, whereas 
DAG activates protein kinase C (PKC), a downstream effector located in the plasma membrane  
(91).   The liberation of Ca
2+
 triggers responses throughout the cell, including  stimulation of 
PKC and the activation of Ca
2+
-sensitive enzymes and of a Ca
2+
-binding protein, calmodulin 
(91).   The α2ADR is linked to the G-protein inhibitory complex (Gi), which, when activated, 
downregulates activity of the adenylyl cyclase enzyme, and consequently, production of cAMP 
(91).    In turn, reductions in cAMP levels inhibit cAMP-dependent protein kinase A (PKA) 
activity—a key enzyme responsible for the phosphorylation of downstream effectors (91).  
 The β-ADR exists in the β 1, β 2, and β3 isoforms (reviewed recently 152 and 153), which 
are linked to the transmembrane G-protein stimulating complex (Gs), another GPCR.  Activation 
of Gs increases activity of adenylyl cyclase, resulting in an increase in the intracellular levels of 
cAMP (91).  The increased cAMP levels activate PKA, which phosphorylates downstream target 
proteins.  Many enzymes (e.g., lipases and glycogen phosphorylase) are activated by 
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phosphorylation, whereas the catalytic ability of other enzymes (e.g., pyruvate dehydrogenase 
and glycogen synthase) are deactivated when phosphorylated by PKA (91).   Termination of the 
activating signal (i.e., the neurotransmitter) results from the degradation of the neurotransmitter 
by monoamine oxidase (MAO) or catechol-O-methyl transferase (COMT), reuptake of the 
neurotransmitter by the presynaptic neuron and/or reuptake within the plasma membranes of 
non-neuronal cells in the vicinity (154).  Inhibitors of COMT and MAO (MAOIs) prevent the 
breakdown of catecholamines, which increases their availability and greatly exaggerates the 
effects of the activated ADR (154).  Due to potentially lethal drug and dietary contraindications, 
MAOIs are usually a last resort for the treatment of a wide range of psychiatric phenotypes 
including, depression, agoraphobia, social anxiety, and Parkinson’s disease (155). 
 Epinephrine is considered to be the most potent, endogenous agonist of both groups of 
receptors, while the effects of NE are most pronounced on the α and β1 receptors (91, 148).   
Thus, the adrenal medulla is central in the systemic activation of the ADR via release of E.  
Vasoconstriction of the blood vessels leading to the heart, skeletal muscles, genitalia and adipose 
tissue is mediated solely by NE, except in cases where more than one ADR type is represented 
(91, 148).   In these cases, binding of E to the α- and β2-ADRs  results in vasoconstriction or 
vasodilation, respectively,  depending on plasma concentrations of the ligand (91, 148).   
Although the α-ADR is less sensitive to E when activated, this receptor dominates the 
vasodilator effects of the β2-ADR (91).   As a result, high levels of circulating E cause 
vasoconstriction, while lower levels of circulating E enhance β-ADR stimulation, producing 
overall vasodilation.  In this way, a single catecholamine can have differential effects, which are 
mediated by the binding  affinity and serum concentration of the neurotransmitters as well as the 
makeup (or composition) of  the ADR population on the surface of the effector (91, 148).   
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 Aside from controlling vasomotor activity of the blood vessels, the adrenergic receptors 
mediate the contractile behavior of cardiac muscle, smooth muscle within the GI, respiratory and 
urogenital systems, endocrine function of the pancreatic (150).   The ADR also mediates 
lipolysis, which is a multistep, catabolic process whereby triglycerides (TAG)—high-caloric 
molecules stored in white adipose tissue (WAT) pads located in the abdominal and thoracic 
cavities, subcutaneously, and within muscle and liver (156)— are hydrolyzed into free fatty acids 
(FFAs) and glycerol (reviewed previously, 157).    Before entering into blood, the FFAs are 
conjugated to a water-soluble, plasma protein called albumin (157).  Inside of target cells, FFAs 
are oxidized as fuels yielding acetyl-CoA, which powers the Krebs cycle, and ketone bodies, 
which act as a secondary fuel source for the brain (157).   Various reproductive and metabolic 
functions that are mediated by the adrenergic receptor family are reviewed in the following 
sections within the context of primary research. 
 Neural control of male reproduction.  As discussed previously, the development and 
proper functioning of the male reproductive tract are largely the result of hormonal influences, 
however, the successful completion of the principal reproductive event (i.e., insemination of the 
female) requires exact timing, and consequently, the involvement of the CNS (158) and ANS 
(66).  For example, sexual arousal brought about by psychogenic stimuli and the physical 
stimulation of the male (and female) genitalia, followed by the events of the sexual act, is 
mediated by the somatic (voluntary motor) and autonomic nervous systems (75).  Specifically, 
the medial preoptic area of the anterior hypothalamus and limbic areas of the CNS mediate 
sexual arousal (159), whereas autonomic neural control of the mammalian male reproductive 
organs by the SNS (42, 160-167) and the PSNS (162, 166, 168) ensure the proper functioning of 
the testes (i.e., androgen production and spermatogenesis)  and successful fertilization, which 
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involves penile erection and glandular secretion.   Thus, neural control of reproduction facilitates 
synchronized responses throughout the male reproductive tract and whole body, and most likely 
evolved to ensure the perpetuation of the species (75).   
 Innervation of the male reproductive organs is accomplished by three, major sets of nerve 
fibers—lumbosacral, sacral parasympathetic and the thoracolumbar sympathetic nerves—which 
converge at the pelvic plexus (159, 169).  According to a review of the pelvic plexus by Dail 
(170), the interaction of the these nerve fibers at the pelvic plexus is not well understood.  The 
lumbosacral outflow to the reproductive tract includes the genitofemoral (=inguinal), pudendal, 
and in certain species (e.g., man and equine), the ilioinguinal nerves (for review, see ref. 171).  
The genitofemoral nerve, which arises from the lumbar plexus at spinal roots L1 and L2, 
supplies the cremaster muscle and scrotal skin (171, 172).  Originating in the sacral plexus, the 
pudendal nerve derives fibers from nuclei in the dorsomedial (DM) and dorsolateral (DL) cell 
columns near spinal segments L5-L6 and from the ventral branches of the second, third, and 
fourth sacral nerves (S2, S3, S4, respectively; 169, 173, 174).  The pudendal, which at least in 
rat, branches into motor and sensory divisions at the level of the ischium nerve, supplies 
somatosensory innervation to the genitalia, specifically to the penis, scrotum, and perineum 
(169).  The motor pudendal division carries somatic fibers to the striated penile muscles, whereas 
both divisions carry efferent sympathetics (involuntary motor) to the bulbospongiosus and 
ischiocavernosus muscles (63, 169).  Stimulation of the bulbospongiosus and ischiocavernosus 
results in erection and the spasmodic contractions of sexual climax, which generally involve 
ejaculation and the euphoric sensation of orgasm (reviewed in 175). The ilioinguinal derives its 
fibers from L1 and innervates the skin over the root of the penis and the upper part of the 
scrotum (169). 
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 The diffuse and extensive autonomic neural projections to the male genitalia have been 
described in cat (166), rat (176) , camel (161) and other animal species (79, 177-179).  
Accounting for less than 30% of the neuronal input to the sex accessory organs, the PSNS 
represents a minor contribution to the male reproductive genitalia (66).  The primary source of 
parasympathetic input to the male reproductive organs is the PSN (149, 170, 180).  The PSN 
receives virtually all of the parasympathetic neurons exiting the sacral spinal cord (149),  
supplying vasodilator (proerectile) control to the cavernous smooth muscles and vasculature of 
the penis (66, 170) and visceral afferent fibers to the  pelvic plexus (171).  Hill and Toivola (164) 
reported that sacral cordotomy, which is transection of the parasympathetic portion of the spinal 
cord at the lumbosacral articulation, significantly reduced the testicular weights and serum levels 
of testosterone of male guinea pigs. Transected pigs had severely atrophied seminiferous tubules, 
which showed little spermatogenic activity, whereas the epididymi of transected males lacked 
sperm (164).   Considering the lack of empirical evidence demonstrating significant cholinergic 
innervation of the testis,  outside of the testicular capsule and supporting vasculature (79), the 
findings of Hill are perplexing to say the least.  Numerous groups have reported disruptions to 
spermatogenesis, the pituitary-gonadal axis, and testicular blood flow following spinal cord 
injury (SCI), which ultimately causes irreversible infertility in man (181-183) and the Sprague-
Dawley rat (124, 184-194), whereas Campos reported that the testis is richly innervated by 
catecholaminergic (195) and serotonergic fibers (196).  Thus, it is plausible that the surgical 
procedure performed by Hill and Toivola incidentally severed the sympathetic fibers to the testis 
(and possibly epididymis), which has been shown to cause spermatogenic defects and induce a 
pathophysiologic condition in testicular function (42, 43, 197, 198).  For these reasons, the 
remainder of this discussion will focus on the role of the SNS in mediating male reproduction.  
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 The testicular vasculature is innervated by adrenergic and peptidergic fibers.  Using 
techniques common to classical immunocytochemistry (ICC),  Rauchenwald et al. (163) reported 
that while VIP-ir  neurons were not detected within the testis, NPY-ir neurons were dispersed 
throughout the tunica albuginea and superficial vasculature.  The results of a subsequent study by 
Lakomy (165) corroborated the findings of the Rauchenwald group,  demonstrating the presence 
of noradrenergic and peptidergic markers, which varied in degree between the cauda epididymis, 
testicular capsule and parenchyma of adult boars.  Zhu et al. (79) reported that neurons 
immunoreactive for VIP, calcitonin gene-related peptide (CGRP) and C flanking protein of NPY 
(CPON; a marker for NPY) were present in the intracapsular interstitium and testicular blood 
vessels, although no neurons were found innervating the testicular parenchyma, seminiferous 
tubules, and the intratesticular area of the rete testis of the rat.  The discovery of sparsely 
distributed catecholaminergic neurons throughout the vasculature and capsule provided new 
insight on the innervation of the testis (79, 163, 199).   
 Exiting from the thoracolumbar segments of the spinal cord, the lumber splanchnic 
(LSN) and hypogastric nerves mediate smooth muscle contraction of the testicular capsule (79, 
163, 176), epididymis (200), and vas deferens (201-207), which propels the sperm out of the 
testis and into the epididymis and through the seminal tract during seminal emission (175, 208).  
The sympathetic nerve fibers also mediate glandular secretion of the seminal vesicles, 
bulbourethral and prostate glands during the ejaculatory event (66, 80, 170, 209, 210).  
Investigations involving the surgical treatment of testicular tumors in man have added to our 
understanding of the role of the LSN in the reproductive process.  Ipsilateral or contralateral 
electrical stimulation of the LSN, during  nerve-sparing, laparoscopic retroperitoneal lymph node 
dissection (L-RPLND), resulted in unilateral seminal emission on the stimulated side, which was 
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recorded by an endoscope inserted into the urethra (211).  Although cross innervation of the vas 
deferens and ejaculatory ducts is widely accepted in other mammals (201, 202, 206),  the results 
of this study ruled out cross innervation in humans and provided evidence for the ipsilateral, 
sympathetic efferent control of seminal emission (211).  
  Electrical stimulation of the LSN of canines, which arises from spinal segments L1-L2  
and synapses onto the caudal mesenteric ganglion  (which corresponds to the IMG and superior 
hypogastric ganglia in humans), resulted in seminal emission (203).  Conversely,  electrical 
stimulation of the thoracic splanchnic nerves, which originate from spinal segments T5 -T12 and 
synapse onto the CG and SMG, did not result in seminal emission (203).  Similar investigations 
in canines demonstrated that transection of the spermatic nerves (to be discussed later), followed 
by electrical stimulation of the distal end of the severed nerve, did not cause seminal emission 
(200).  However,  electrical stimulation of the same portion of the severed spermatic nerve a 
month later, accompanied by transection of the hypogastric nerve and lumbosacral spinal cord,  
produced seminal emission (200).  These findings indicate that the superior spermatic nerve, 
which arises, in part, from the upper lumbar sympathetic trunk, may provide a compensatory 
route for seminal emission if the hypogastric nerves or LSN are damaged.  
 The role of the spermatic nerves in testicular function.  The contributions from the 
superior and inferior spermatic nerves (SSN and ISN, respectively) represent the principle supply 
of catecholaminergic input to the mammalian testis (66, 79, 195, 212), although an intratesticular 
source of catecholamines, which is not reviewed here, has been reported recently (213-216).  The 
SSN carries output from the renal, spermatic, aortic, and mesenteric plexuses and descends 
bilaterally into the superior pole of the testis inside the spermatic cord (Fig. 1b).  The SSN, 
which also receives afferent and possibly vagal parasympathetic fibers (171, 217), is carried into 
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the testis alongside the internal spermatic (=testicular) artery (61, 79).  Originating primarily 
from branches of the pelvic and inferior mesenteric plexuses, the ISN, which carries mostly 
sympathetic fibers, accompanies the vas deferens to penetrate the cauda epididymis near the IL, 
where it penetrates the testis, although to a lesser extent than does the SSN (79, 180, 218).  
 The role of the SNS in testicular function, specifically, spermatogenesis, androgen 
production, testicular blood flow, and seminal emission was elucidated by selective nerve 
transection and stimulation (electrical) experiments involving the SSN, ISN, and lumbosacral 
spinal cord.  Previous investigators observed alternations to spermatogenesis and/or testicular 
endocrinology following testicular denervation by surgical (42, 43, 197-199, 212, 219-222) and 
chemical means (35, 223-225) and after SCI  (42, 43, 124, 181-191, 193, 194, 197-199, 212, 221, 
222), which suggest that nonendocrine mechanisms (i.e., neural input) mediate normal testicular 
function—specifically, germ cell differentiation, development, androgenesis, and maintenance of 
the germinal structural integrity.  Chow et al. (42) surgically transected the SSN and ISN of adult 
rats and observed a significant regression in spermatogenesis, increased phagocytosis of mature 
sperm, and delayed spermiation, whereas other groups observed atrophy of the testes, 
degeneration of the seminal tubular epithelia, and hypertrophy of interstitial secretory tissue 
following interruption of testicular innervation in dogs (226), guinea pigs (227) and rabbits 
(219).  In stark contrast, Frankel and Ryan (228) reported that bilateral denervation of the 
spermatic plexus, which gives rise to the SSN, produced no effect on testicular weights, serum 
testosterone levels, spermatogenesis, or mating behavior.  The authors reported that the pelvic 
nerve plexus (which supplies the ISN) was left intact, which may explain these conflicting 
findings. 
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 As the principle neurotransmitter substance of postganglionic sympathetic neurons, much 
study has been devoted to the role of NE in mediating spermatogenesis and androgen production.  
Recall that binding of NE to the α1βADR activates hydrolysis of phosphatidylinositol (PI), which 
upregulates mitosis, thereby enhancing cell proliferation (229-231).  Allen et al. (229) showed 
that transfection of rat fibroblasts with a plasmid containing a constitutive-activating mutation in 
the α1BADR gene:  i.) increased expression of the wild-type α1BADR within the mutant 
fibroblasts, ii.)  enhanced the mitogenic effects of NE on mutant fibroblasts, and iii.)  promoted 
tumor development in nude mice injected with mutant fibroblasts.  Mhaouty-Kodja et al. (230) 
described novel effects of NE on male gonadal function, presumably through its activation of the 
α1BADR in male mice.  Adult mice, which were homozygous for mutations in the α1B-adrenergic 
receptor gene (α1BADRKO), showed decreased testicular weights, whereas the undifferentiated 
germ cells of α1BADRKO mice entered into an apoptotic pathway at meiosis (230).  
Additionally, α1BADRKO mice exhibited severely reduced concentration of serum T, resulting in 
significantly elevated serum LH levels when compared to the wild-type controls (230).  
Consequently, approximately 30% of the mutant mice were infertile due to premature apoptosis 
and abnormal serum T (230).  Intratesticular production of inhibin was increased in the 
α1BADRKO mice, which was correlated with increased expression of the inhibin gene (230).  
Finally, in situ hybridization demonstrated that α1BADR messenger RNA (mRNA) was present 
in the early spermatocytes of the wild-type testis (230).   Publications by Mayerhofer (223) and 
Campos et al.(212) may serve to explain the elevated levels of LH reported by Mhaouty-Kodja.  
Mayerhofer reported that injection of 6-hydroxydopamine (6-OHDA), a neurotoxin which 
selectively targets the noradrenergic neurons of the SNS, significantly reduced the concentration 
of LH-R and testicular T in the hamster testis after 24 hours (h), as compared to vehicle-treated 
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control, contralateral testis (223).  Injection of NE into previously untreated hamsters reduced the 
concentration of the LH-R and testicular T after 24h, which suggests that NE may downregulate 
gonadal function during stress (223).   At 72h, the LH-R and testicular T levels were 
significantly increased, whereas LH-R and T levels of animals sacrificed at 10h, 48h, 144h (6 
days), or 168h (7 days)  were not significantly different as compared to controls (223).  At144h 
and 168h, the testicular weights of animals treated with 6-OHDA or NE was significantly 
reduced, an effect which was secondary to the degenerative morphological changes in the 
seminal epithelium, including the invasion of neutrophils into the lumina of centrally-located 
tubules (223).  Bergh (232) demonstrated 6-OHDA had no effect on germinal morphology or 
spermatogenic ability in rats after a 49-day treatment period, which suggests that 6-OHDA 
treatment may be ineffective in suppressing testicular function following prolonged exposure to 
the neurotoxin. Subsequent investigators replicated these findings,  demonstrating that bilateral 
transection of the SSN nerve in rats decreased the number of LH receptors and significantly 
reduced the in vitro production of androgen in response to hCG stimulation (212).   In theory, the 
reduction in LH-R and T caused by 6-OHDA treatment and SSN denervation may have led to 
over secretion of LH in the α1BADRKO mice.  Together, the findings of Mhaouty-Kodja and 
Campos suggest a central role of NE (and thus, the ANS) in gonadal function in demonstrating 
that disruption of adrenergic receptors indirectly impairs germ cell development by 
compromising Leydig-Sertoli cell communication and androgenesis (230).  Moreover, these 
studies suggest that NE, through its activation of the α1BADR, might be critical for promoting the 
synchronized mitogenic activity of spermatogenesis.  
 Lamono-Carvalho et al. (167, 233) reported that selective guanethidine-induced 
sympathectomy of the epididymis and vas deferens of prepubertal male rats increased 
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intratesticular progesterone levels and reduced the intratesticular androstenedione and T levels, 
yet had no effect on spermatogenic ability of the testis.  In late-pubertal and adult rats, 
guanethidine therapy increased the concentration of spermatozoa in the caudal epididymis,  
indicating the inability of sympathectomized males to emit semen, control fluid resorption, and 
clear unejaculated spermatozoa (233).  Moreover, pre-pubertal rats subjected to subcutaneous 
injections (10 mg/kg/day) of guanethidine (GD),  an inhibitor of NE release from sympathetic 
preganglionics, show significantly elevated intratesticular progesterone levels, reduced T levels, 
which were purportedly caused by the ―specific blockade‖ of 17-α-hydroxylase affected by GD 
therapy (234).  Catecholamine content assays confirmed denervation of the testicular tissue, 
whereas histological analysis confirmed that spermatogenesis was not affected by the GD 
therapy (234).  These findings are largely in concert with published studies in adult rats, which 
report that spermatogenic ability of the testes, serum levels of T and LH, fertility of epididymal 
sperm are unaffected by guanethidine-induced sympathectomy of the epididymis (191, 235).     
 The role of the SSN and ISN in T secretion and spermatic blood flow (SBF) was 
elucidated in classical electrical stimulation experiments.  These studies demonstrated that 
moderate (25-35V)  to high-intensity (36-70V) electrical stimulation applied to the SSN in cats 
increased plasma concentration of T within the spermatic vein, but decreased the overall SBF 
though this vessel; NE concentrations in arterial blood and the spermatic vein also increased 
from basal values after electrical stimulation (67).   Conversely, moderate stimulation of the ISN 
had no effect on plasma concentrations of T, NE output, or SBF, whereas high-intensity 
stimulation increased SBF only (67).  It is important to note, however, that heart rate and mean 
arterial pressure (MAP) did not change with the fluctuations in SBF, suggesting that the 
modifications in vascular diameter were elicited by neuromediators (67).  The differential effects 
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of electrical stimulation of the SSN and ISN on T concentration and testicular blood flow:  i.) 
provide evidence for the neural control of T secretion and ii.)  demonstrate that vascular tone of 
the spermatic artery is mediated by adrenergic input from the SSN and ISN that control arterial 
vasoconstriction and vasodilation, respectively (67).  
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III. Energy availability, reproduction, and white adipose tissue 
 Warm-blooded animals require a constant supply of energy to power the life-sustaining 
metabolic activities of the cell that maintain body temperature and power biosynthetic pathways.  
Thus, in an energy deficit, organisms suspend energetically-expensive functions, such as 
gametogenesis, gonadal steroid production, and lactation, which are not critical for the 
immediate survival in favor of function that sustain life (reviewed in 236 , 237).  The evolution 
of neural, metabolic, and endocrine signals, which mediate the crosstalk between critical 
metabolic pathways and non-critical reproductive functions, ensured that life-sustaining 
processes, such as cell growth/development, aerobic respiration, and thermoregulation, continued 
during prolonged metabolic challenges—e.g., when the levels of circulating (e.g., carbohydrates) 
or stored fuels (e.g., glycogen and triglycerides) dropped below a critical value (236, 238).   
 Carbohydrate oxidation, a stepwise process and ubiquitous hallmark of heterotrophic 
organisms, is the preferred method of energy transfer in warm-blooded animals.  During 
metabolic challenges circulating fuels and glycogen stores are generally depleted first, followed 
by release of triglycerides from WAT (i.e., lipolysis), which ensures that energy needs are met 
and life-sustaining process are not compromised (156, 239-243).  However, when WAT stores 
are depleted, non-critical processes, such as those that support reproduction, are severely 
compromised (237).  The direct relation between availability of energy and reproductive fitness 
is especially true in females, whose reproductive costs some believe to be greater than that of 
males (237, 239, 244-248).  Frisch (249) reviewed a large body of evidence which provides 
strong evidence that excessive leanness caused by malnutrition, rapid weight loss or heavy 
physical exercise disrupts normal energy metabolism and reduces gonadotrophin and estrogen 
secretion, thereby preventing menarche in prepubertal girls, while lessening the reproductive 
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ability and fertility of athletic women.   Food-restriction studies done in prepubertal female rats 
demonstrate that when energy levels drop below certain critical values, secretion of GnRH is 
inhibited which, in turn, inhibits secretion of pituitary LH, decelerates follicular development 
and disrupts ovulation (237, 240, 241, 244, 250, 251).  Additionally, partial excision of the 
parametrial white adipose tissue (PWAT) depots surrounding the ovaries of pregnant, Djungarian 
hamsters produced no effect on the litter or pup size, but inhibited the investment in a second 
reproductive attempt, while decreasing the size of second litters as compared to the size of 
second litters in control females (252).  Thus, internal control mechanisms—mediated by the 
neural and humoral signals mentioned previously—monitor the availability of reserve and 
dietary energy, which allow animals to prioritize their reproductive functions and behavioral 
options, especially when nutritional needs are unmet (236, 237, 240, 241, 253).  
 35 
IV. Role of white adipose tissue in male reproductive function 
 The role of the gonadal WAT in mammalian reproduction.  Although well documented in 
human females (236, 237, 244, 246, 254, 255), rodent (244, 250, 252, 253, 256),  Rhesus 
monkey (257) and dairy cow (245, 247, 248), the exact role that energy availability or reserves 
plays on reproductive function in males, specifically gonadotrophin secretion,  androgenesis, 
spermatogenesis and mating behavior, is less understood and begs to be explored.  Previous 
investigators demonstrated that bilateral removal of the gonadal epididymal white adipose tissue 
(EWATx) decreased spermatogenic activity in albino rats (258) and Syrian hamsters 
(Mesocricetus auratus; unpublished data), whereas unilateral or bilateral removal of an equal 
amount of the non-gonadal inguinal white adipose tissue (UNI-IWATx and IWATx, 
respectively)—with or without transplantation of the excised IWAT pads under the dorsum of 
the donor hamster—had no effect on spermatogenesis as measured by ejaculatory sperm counts 
(unpublished data).   Moreover, male mating behavior—indicated by mount, intromission, and 
ejaculation frequencies (see 259 for descriptions of rat copulatory behavior)—did not differ 
significantly between any of the experimental group, however the ejaculate recovered from the 
vaginas of females mated with EWATx males contained virtually no sperm, even when the 
excised EWAT pads were transplanted dorsally (unpublished data).  Conversely, the ejaculate 
recovered from females mated with IWATx (with or without transplantation) and UNI-IWAT 
males was abundant in sperm (unpublished data). 
 Microscopic examination revealed that the seminiferous tubules of EWATx rats were 
markedly atrophied (258), whereas quantitative measurements revealed that (on average) the 
testes of EWATx hamsters had significantly thinner seminal tubule epithelial widths and fewer 
sperm than the hamsters which received unilateral EWAT removal (UNI-EWATx) or sham 
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surgery (unpublished data).   Compared to the sham controls, relatively normal spermatogenesis 
and normal seminal tubule widths were observed in the EWAT-intact testes of UNI-EWATx 
males, however, the contralateral, EWAT-lipectomized testis within the same hamster had 
significantly fewer sperm-positive tubules, reduced sperm counts, and thinner epithelial widths 
(unpublished data).   
 Hormone radioimmunoassay (RIA) revealed that plasma levels of FSH were significantly 
higher in EWATx hamsters than in the UNI-EWATx or shams, suggesting loss of testicular 
inhibitory signals which downregulate the hypothalamo-hypophyseal axis (unpublished data).  
For instance, the marked seminal tubule atrophy and germ cell degeneration of the EWATx testis 
might indicate a regression in Sertoli cell function, especially in the maintenance of tight 
junctions and in the secretion of ABP and inhibin—a key inhibitory signal of  GnRH and FSH 
secretion.  Circulating levels of LH and T did not differ significantly between the experimental 
groups, indicating that testicular (and adrenal) androgenesis was normal in all groups 
(unpublished data).  The value of the summed intratesticular NE levels from both testes of the 
EWATx males was significantly depressed when compared to that of the sham controls, whereas 
the NE content of the prostate gland did not differ significantly between these two groups 
(unpublished data).  While tentative, the reduced NE levels suggests that the EWATx testes were 
incidentally denervated by the EWAT lipectomy surgery, which implies that the EWAT and 
testis share a common neural supply via an en passant neural connection which might course 
first through the EWAT en route to testis.  Moreover, the relatively unremarkable gonadotrophin 
and T serum profile of the EWATx group raises an important question:  Considering that 
secretion of FSH, LH, and T in EWATx males was not severely impaired, why were the tubular 
lesions and anti-spermatogenic defects of the EWATx procedure not ameliorated or altogether 
 37 
prevented?  A highly probable answer to this question might be found in studies done in 
Amphibia, which are discussed later in this report. 
 The weights of the emptied or fluid-filled sex accessory organs (seminal vesicles and 
prostate glands) of the EWATx, UNI-EWATx, and SHAM males did not differ significantly 
from each other, whereas the average weight of both testes of EWATx males was significantly 
lower that of the latter two groups, which did not differ significantly from each other 
(unpublished data).  While the epididymal sperm counts of the latter two groups did not differ 
significantly from each other, epididymal sperm count measures could not be performed for the 
EWATx animals, owing to epididymal atrophy in some males and the total absence of the 
epididymis in others (unpublished data).  Srinivasan et al. (258) noted that EWATx rats 
sacrificed 15 days after the lipectomy procedure had significantly lower testicular and accessory 
organ weights (prostate, epididymis, seminal vesicle) than that of the sham controls, while 
spermatogenetic activity and accessory organ weights of animals sacrificed 30 days post-
lipectomy did not differ significantly from control values.  The latter finding suggests that the 
health of the internal genitalia and spermatogenesis might be restored in a time-dependent 
fashion following EWAT removal, which the authors contribute to the regrowth of EWAT in 
only the rats sacrificed 30 days post-lipectomy (258).  Cohen et al. (260) reported that excision 
of an EWAT fat pad in rat resulted in a significant increase in the weight and fat content of the 
contralateral pad within 3 days of the lipectomy procedure, despite a decrease in body weight.   
No significant differences in size were detected in the intact fat pad size when longer periods 
were tested (260),  a finding which was replicated in experiments by Mauer and Bartness (261) 
wherein UNI-EWATx Siberian hamsters (Phodopus sungorus) were sacrificed 12 weeks post-
lipectomy, and by other investigators (unpublished data).     
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 The subsequent regrowth of EWAT pads following bilateral excision (258), as well as the 
accelerated growth of the EWAT after excision of its contralateral mate (260),  may have been 
caused by a blood-borne (humoral) factor of EWAT origin that became less active with time, a 
theory which was first proposed by Cohen et al. (260).    Mauer and Bartness (262) extended the 
ideas of Cohen, proposing that that total body fat might be regulated by humoral and/or afferent 
(sensory) signals released from WAT pads throughout the organism in response to changes in 
total body fat.  These signals would target energy-monitoring centres within the CNS (possibly 
the hypothalamus and brainstem), which, via sympathetic efferent projections to WAT, mediate 
various compensatory responses, including increasing white adipocyte proliferation and 
decreasing the lipolytic activity of intact WAT pads (262). 
  The role of the gonadal WAT in amphibian reproduction.  Studies on the fat body (FB) 
stores of several amphibian species, including the Green frog (R. esculenta) and Rana 
hexadactyla Lesson (no common name), may provide further insight into the role of the gonadal 
fat stores in mammalian reproduction and furnish an answer to the question posed in the previous 
section.  Sharing a common mesodermal origin with the gonads, the FBs are finger-like 
structures bilaterally situated at the cephalic end of the gonads of both sexes (263, 264).  These 
fat stores represent the largest lipid (triglyceride and cholesterol) deposits in the amphibian body 
(263-265), comprising nearly 7% of total body weight (266).   Zancanaro (263) noted that the 
FBs of frogs caught after winter hibernation contained lipoproteinlipase (LPL) and S-100 
protein, markers generally associated with mammalian adipocytes (157).  Conversely, the 
adipocytes of the amphibian fat body lacked a definite external lamina, but instead possess 
cellular prolongations and spike-like projections (―spicula‖) produced by extrusion of the cell 
membrane, features not observed in mammalian adipocytes (263).   
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  Dubois (267) reported that partial orchidectomy resulted in the enlargement of the FBs,  
a discovery which was the basis of an early theory concerning the secretion of a nutritive or 
hormonal factor from the amphibian FB which may sustain gonadal function.  Evidence in 
support of Dubois’s theory was presented by Chieffi (268), who isolated steroid hormones from 
the FB of male Northern crested newts (Triturus cristatus carnifex), whereas other workers (cited 
in 264) reported that the FB of this same species contained steroidogenic enzymes, which could 
use cholesterol as the precursor molecule.   Moreover, bilateral extirpation of the fat body (FBX) 
resulted in ovarian atrophy in females and degeneration of the ―sexual products,‖ i.e., spermatids 
and spermatozoa of male newts (Notophthalmus uiridescens; 53).    Fat body removal also 
inhibited protein synthesis, uptake of lipids, and attenuated the ovarian growth of R. esculenta 
during recrudescence (263, 269).  Das (266) reported that the masses of the FBs and livers of 
adult male R. hexadactyla caught during the peak mating months were smaller than in frogs 
caught in other times of the year.   The size and masses of these organs in male frogs fluctuated 
inversely with spawning peaks, suggesting that FB contents may support courtship behavior 
and/or spermatogenesis (266).  However, Das reported that only the FB, and not the liver masses, 
of adult female frogs showed seasonal variation.  Lastly, the size of the abdominal (visceral) 
depots showed seasonal peaks in both male and females, which were correlated to fluctuations in 
feeding peaks.  Das concluded that TAG stored in the gonadal FBs are most likely used for 
reproduction and not for maintenance during periods of increased nutritional stress (i.e., the dry 
season), since the FBs and livers of males during the dry season are larger than in other times of 
the year (266).   
 Zancanaro (263) replicated the findings of Das (266), reporting that the FBs of frogs 
caught in the fall month of August were consistently larger than the FBs of frogs caught during 
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the peak mating season in May, however, the FBs of females were consistently larger than that of 
males during all seasons (263).  The reduced fat body (lipid) content of the May frog provides 
evidence that the lipid stores were consumed to support the increased gonadal activity during the 
mating months (263).   Microscopic analysis revealed that intercellular contact between adjacent 
adipocytes in the May frog is maintained by interdigitations of the plasma membrane, whereas 
the presence of prominent Golgi complexes and pinocytotic vesicles supports the theory that the 
active cellular secretion of lipids increased during the mating months (263).    
 To date, Chieffi et al. (265, 270) provides the strongest evidence in support of Dubois’s 
theory (267)  in the amphibian model.   Chieffi et al. (265) reported that FBX in adult frogs 
resulted in rapid germ cell degeneration and testicular lesions, noting that the general pathologic 
pattern began in the central ―testicular elements‖ and later spread to the peripheral seminal 
tubules.  Atrophy of the testes following FB removal led to compensatory gonadotrophin 
hypersecretion as measured by changes in the cytology of the PD (265). Unilateral FBX 
experiments caused histopathological damage to the ipsilateral testis only (265, 271), whereas 
India ink tracing studies confirmed that the testicular vasculature had not being damaged during 
the FBX procedure (265).     Interestingly, the onset of testicular atrophy and germinal 
degeneration in fall-caught frogs was delayed following FBX, whereas the histopathological 
effect of FBX on the testes of spring-caught frogs was rapidly manifested  (265).  Thus, when 
demand for the putative FB nutrient(s) is high, which is secondary to the increased gonadal 
activity of the spring season, the FBX procedure resulted in rapid testicular atrophy and germ 
cell depletion, whereas the inverse is true following FBX during the low-demand (autumn) 
season.  To study the ability of extracts of the FB to restore testicular function, the researchers 
performed replacement experiments where FB homogenates were separated into aqueous (FB-A) 
 41 
and lipid (FB-L) fractions using a multistep, solvent extraction procedure (265).   Compared to 
the controls, intraperitoneal (i.p.) injection of the FB-L fraction was highly significant in 
reversing the effects of FBX, even more so than the FB-A fraction or total FB homogenate (265).  
  Removal of the pars distalis (PDX) produced defects in the testicular histology, which 
were similar to those caused by FBX, however, the degree and rapidity of pathology following 
PDX was less severe than those caused by FBX (265).  Moreover, whereas transection of the 
hypothalamo-hypophyseal tracts or PDX did not significantly affect FB weight loss (FBWL), 
administration of a PD homogenate to PDX animals caused a highly significant increase in 
FBWL, while administration of a hypothalamic homogenate alone did not affect FBWL (265).  
Conversely, i.p. injection of hypothalamic homogenates into PD-intact animals led to a rapid, 
highly significant increase in FBWL (265).  Chieffi et al. (265) and other researchers (264) 
reported that castration resulted in rapid FBWL, a finding which, at first, is largely inconsistent 
with the findings of Dubois, although the former group of researchers did not address this 
inconsistency in their report.  It is highly probable that partial castration lessened the testicular 
demand on the FB (267), while the continued production of inhibitory signals (e.g., inhibin & T) 
by the intact remaining testicular tissue suppressed the hypothalamo-hypophyseal axis and 
secretion of the fat-mobilizing factor (FMF)—two effects which could have led to the 
hypertrophic FB growth (267).  Total castration, however, completely removed these inhibitory 
signals, which, in turn, resulted in FMF hypersecretion, and consequently, an increase in FBWL 
(264, 265).   
 Lipid mobilization, gonadal function and identification of novel lipolytic agents.  In a 
fascinating model, Chieffi et al. (265) theorized that a novel FMF secreted from the PD mediates  
the mobilization of FB contents into the amphibian testis.  According to Chieffi’s model, the 
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subsequent production of testicular steroids and other inhibitor products might regulate the 
secretion of a hypothalamic-releasing factor, which, in turn, controls production/secretion of the 
FMF (265).  Anatomists have long since established that the vascular supply of the amphibian 
testis and FB is independent , while lanthanum tracing experiments confirmed the presence of a 
vesicular-tubular system within the fat body, which presumably connects the adipocyte 
cytoplasm with the interstitial spaces of the fat body (263).  Chieffi et al. (265) used India ink to 
trace a portal system between the gonads and FBs, which, along with capillary intervening 
network of the two structures, may serve as a conduit for the direct transport of the liberated fat 
body contents into the testis.  In the testis, the FB contents might have several actions, including 
supporting steroidogenesis and germ cell development, mediating Sertoli cell function, or 
supplying mitogenic factors.  The authors proposed that LH and FSH are incapable of 
stimulating the testes in the absence of the FB (or its contents), which explains why the 
pathogenic effects of FBX (and possibly EWATx) were not corrected by hypersecretion of the 
gonadotrophins from the basophilic (A1 and B2) cells of the PD (265).   
 Chieffi et al. (265) demonstrated that the hypothalamo-hypophyseal axis controlled the 
mobilization of stored body fat through release of a FMF, a hypothesis first proposed and tested 
by Best and Campbell (272, 273), which sought to explain the mobilization of fat into rat liver 
following administration of an anterior pituitary extract.  Seifter and Baeder (274) reported that 
injection of cortisone increased the concentration of a lipid-mobilizing factor (LMF) in the 
plasma of horse and man, whereas repeated intravenous or intramuscular injection of the LMF 
into rat resulted in hyperlipemia and loss of body weight, despite inducing hyperphagia.  The 
LMF was not detected in the plasma of hypophysectomized rats (274), yet intravenous injection 
of a dialysate containing the LMF caused hyperlipemia within this group (274) doubled the 
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serum concentrations of cholesterol, FFAs, and phospholipids of human subjects.  Conversely, 
the dialysate had no effect on serum glucose levels (275).  Considering that the LMF was 
undetected in rat plasma following removal of the hypothalamus, it is highly likely that the LMF 
of Seifter and Baeder (274, 275) is secreted primarily from the hypothalamus.  This finding 
effectively rules out leptin (MW 16 kDa), an endocrine hormone secreted principally from white 
fat whose function it is to inform the CNS on the size of peripheral fat stores (for reviews, see 
refs.  254, 276, 277).  Exogenous administration of leptin results in loss of body weight and 
decreased appetite (277), thus it is unlikely the LMF was leptin, as multiple injections of the 
LMF resulted in hyperphagia (274).  Since multiple injections of the LMF resulted in severe 
hyperlipemia in fasted (275) and fed subjects (274),  the researchers concluded that hyperlipemia 
was not induced postprandially. 
 Seifter (278) isolated a LMF from the pituitary gland of hog, whereas other teams 
isolated LMF/FMFs from the pituitary glands of various higher vertebrates, including man (279-
282),  rat and human urine (283, 284),  rat hypothalamus (279, 285) and sheep midbrain (286).  
Larsen (287) described a FMF secreted from the PD of the common toad (Bufo bufo), whereas 
Trygstad (288) isolated a 2.1 kDa FMF from crude pituitary extracts of human. Subsequent 
studies revealed that the adipokinetic effects of the FMF could be prevented by a proteolytic 
factor isolated from human plasma (289-291).  Li (292)  and Seidah et al. (293) characterized the 
chemical and lipolytic properties of γ-lipotropin (γ -LPH; MW 6.9 kDa) isolated from the rat PD, 
whereas Spiess et al.(294) sequenced the amino acid profile of β-LPH (MW 11.2 kDa) isolated 
from the human pituitary gland.  Lastly, Kastin (279) presents a thorough review of several lipid-
mobilizing substances which had been characterized at the time of the report’s publication. 
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  Later studies revealed that the lipotropins are produced from proopiomelanocortin 
(POMC; MW 28-31 kDa
3
), a high-molecular weight precursor polypeptide of 131 amino acids, 
which is cleaved into adrenocorticotropic hormone (ACTH; MW 4.5 kDa
1) and β-LPH by 
prohormone convertases within the corticotrophs of the anterior pituitary (85, 295-297).  The 
successive cleavage of ACTH generates melanocyte-stimulating hormone (α-MSH; MW 1.7 
kDa), whereas β-LPH is cleaved into γ-LPH and β-endorphin (MW 3.5-4 kDa1), thence β-MSH 
(MW 2.6 kDa
1
) and met-enkephalin (MW 573.7 Da) respectively, which occurs within the cells 
of the pars intermedia (295-297).  To distinguish the newly-discovered LMF/FMFs from  
previously characterized lipolytic agents  (e.g., ACTH, GH, α-MSH,  E and NE), early 
investigators employed various biochemical techniques including RIA (298),  gel 
electrophoresis, Sephadex gel filtration, ultraviolet spectroscopy, and diethylaminoethyl (DEAE) 
cellulose chromatography (288, 289, 299).   
 Receptors for the POMC-derived peptides  (or simply, melanocortins) are ubiquitous  
components of many tissue types, thus the functions of the melanocortins are extensive  
(reviewed in 300).  Previous researchers reported that β-LPH modulated adrenal steroidogenesis 
(301, 302), whereas others groups demonstrated that POMC-derived peptides—specifically, β-
endorphin, β-LPH, ACTH, and α-MSH —may mediate Leydig and Sertoli cell development 
(303-307) and testicular androgenesis (303, 304).  Boston (308) presents several lines of 
evidence regarding the lipolytic effects of the melanocortins on white fat. 
 Zinc-α2-glycoprotein (ZAG; MW 41-43 kDa), a water-soluble protein first isolated from 
human plasma (309), is also found in human and mice adipocytes (310-314), human urine (315, 
316) and from the secretory epithelia of the GI tract, breasts, liver, and eccrine sweat glands 
(317).  Binding of ZAG and tumor-derived LMFs to the β3ADR activates the Gs complex, which 
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increases the activity of adenylyl cyclase (312, 318, 319).  As discussed previously, stimulation 
of adenylyl cyclase increases intracellular cAMP levels, promoting the activation of PKA, 
which, in turn, phosphorylates hormone-sensitive lipases (HSL)—hydrolytic enzymes which 
degrade TAG into DAG and monoacylglycerols during the first steps of lipolysis.  The latter two 
compounds are eventually converted into FFAs and glycerol by monoacylglycerol lipase (157).  
Thus, overexpression of ZAG in malignant tumor cells is a marker of cancer and results in the 
subsequent mobilization of lipid stores and cachexia in humans and ob/ob mice (310, 311, 313, 
315, 320, 321).  Bao et al. (310) reported that ZAG gene expression within adipocytes is 
downregulated by exogenous TNF-α, yet administration of a selective agonist of the peroxisome 
proliferator-activated receptor gamma (PPARγ; which is a hormone nuclear receptor, which is 
activated by PGJ2) increased ZAG mRNA levels (310).  These findings demonstrate the local 
(paracrine and autocrine) regulation of ZAG synthesis, while endocrine mechanisms mediate the 
actions of ZAG at more distal targets. 
  The Chieffi group replicated the findings of Kasinathan et al. (271, 322), confirming that 
bi- or unilateral removal of the FB of R. hexadactyla impaired spermatogenesis, whereas 
Kasinathan et al. (323) implicated the B2 and B3 cells of the PD as the primary sites of 
gonadotrophin production.   Kasinathan et al. (323)  reported pronounced changes in the number  
and histocytology of the latter cells following castration (bi- or unilateral; with or without steroid 
hormone replacement) and FBX  (bi- or unilateral; with or without FB extract therapy).  
Together, these findings led to extensive studies by the Kasinathan group that sought to 
characterize:  i.) the steroidogenic and spermatogenic effects of various compounds, including 
cAMP, cholesterol, and the prostaglandins F2α and E2 (PGF2α and PGE2, respectively) and ii) the 
role of the FB in regulation of the hypothalamo-hypophyseal-gonadal axis and in testicular 
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function/maintenance.  A brief review of the literature revealed several roles that the cAMP 
second messenger system and prostaglandins (PGs) in:  i.) regulating spermatogenesis (324-329),   
ii.)  mediating the plasma concentrations and actions of FSH and LH, and the production of T 
(325, 329-332), iii.)  regulating cholesterol and lipid metabolism (330, 331), and iv.) influencing 
seminal accessory organ development (333).  Kasinathan et al. (264) demonstrated that injection 
of either prostaglandin was successful in reviving all spermatogenic stages following FBX, even 
more so than administration of cAMP alone.   As previously reported by the Chieffi group,  
Kasinathan et al. (264) confirmed that injection of a FB extract into FBX male also restored 
spermatogenesis.  Kasinathan et al. (264) proposed from these findings that the prostaglandins 
represent the primary spermatogenic factors of FB origin, while cAMP acts as a secondary 
factor, promoting the, ―completion of the [latter stages of the spermatogenic] process.‖   
 Injection of PGE2 and PGF2α into the dorsal lymph sac reduced the intratesticular level of 
cholesterol, while exerting the opposite effect on the FB cholesterol content within the same 
animal (264).   Of particular note, the reduction of cholesterol following PGE2 injection was 
highly (p < 0.001) significant; however, both PGs increased testicular weight and the seminal 
tubule diameter (264).  These findings suggest several (putative) roles for the PGs, including 
increasing testicular steroidogenesis, while inhibiting FB steroidogenesis.  Alternatively, these 
PGs might prevent the mobilization of cholesterol from the FB into the testis, which would 
effectively reduce the cholesterol-derived synthesis of hormones within the testis (264).  Results 
of parallel experiments performed in rat have a definite bearing on elucidating the role of the 
PGs in gonadal function.  Didolkar  et al. (332) reported that serum gonadotrophin levels were 
not affected following injection of these PGs.  However, injection of PGE2 (but not PGF2α) 
significantly reduced testicular cholesterol levels, whereas PGE2 was shown to increase testicular 
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weight (327, 332).  Blood plasma levels of testosterone  were significantly reduced following 
injection of PGF2α and PGE2 (332).  Considering that both teams observed a reduction in 
testicular cholesterol following administration of PGE2, the findings of the Didolkar team 
substantiate the latter theory regarding PG function (that is, the PGs may prevent the 
mobilization of cholesterol from the FB, and consequently, testicular androgenesis is 
compromised).  In any case, the studies described here provide strong evidence of a cholesterol 
equilibrium between the testis and FB, which might be maintained by a novel, prostaglandin-
mediated mechanism (264, 332).    
 Administration of cAMP, with or without prostaglandins, reduced cholesterol content of 
the FB and testis, suggesting that cAMP and the PGs might differentially affect gonadal function 
(264).  The reduction of FB cholesterol content was not caused by the mobilization of cholesterol 
from the FB to the testis, considering that administration of cAMP, with or without the PGs, led 
to the concomitant and significant decrease in testicular cholesterol content (264).  Instead, these 
findings suggest that cAMP, more so than the PGs, increased the steroidogenic utilization of 
cholesterol within the testes and fat body (264).  Conventional wisdom dictates that if the FB 
provided only PG and cAMP, FBX would result in reduced intratesticular levels of both 
compounds (264), which, in turn, would decrease the steroidogenic activity of the testis, while 
increasing testicular cholesterol.  Kasinathan et al. (264), however, reported that FBX decreased 
intratesticular content of PG and cAMP, while dramatically reducing cholesterol levels to nearly 
a fourth of control values, which provides strong evidence that the gonadal FB might supply all 
three compounds to the testis.  To this end, Veeraragavan et al.(334) isolated 
hydroxylmethyglutaryl-CoA (HMG-CoA) reductase—the enzyme which catalyzes the rate-
limiting step in cholesterol biosynthesis—from the FBs of R. hexadactyla.  This group also 
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C-glucose was incorporated into 
cholesterol molecules produced in the FB, indicating that acetate and glucose could serve as 
precursor molecules for the synthesis of cholesterol (334).  The authors noted that glucose 
resulted in nearly 9.5 times more 
14
C-cholesterol synthesis than acetate, presumably because 
glucose provides an abundant supply of protons for cholesterol biosynthesis unlike the highly-
oxidized acetate.    
 When coupled, the results of these studies suggest that the testis requires cholesterol from 
the FB and from its own stores to synthesize the gonadal steroids (264, 334), while lipid 
mobilization is mediated by the release of a LMF/FMF from the hypothalamus (279, 335), 
pituitary (292, 299, 336, 337) and/or adipose organ (310-312).  Although it appeared that 
testicular steroidogenesis increased following FBX, spermatogenic activity remained severely 
disrupted (264).  The increased utilization of cholesterol, presumably caused by a compensatory 
increase in steroid hormone production within the testis, could not revive spermatogenesis 
without the aid of additional factors from the FB (264)—a highly plausible conclusion regarding 
the role of the FB in spermatogenesis analogous to Chieffi’s (265) conclusions. 
 The thesis set forth by Kasinathan et al. (264), which stated that cAMP and PGs mediated 
the actions of the gonadotrophins and sex hormones,  presupposes that these compounds are 
endogenous to the testis and FB under normal physiological conditions.  To indirectly confirm 
the presence of cAMP within the gonads and FB,  Kasinathan et al. (338) reported that 3’5’ 
cyclic AMP phosphodiesterase (PDE)—an enzyme which converts cAMP to 5’AMP— was 
active in both gonadal tissues, although the activity of PDE was 1.5 times higher in the FB than 
in the testis.   Kasinathan et al. (264) reported that FBX increased the concentration of several 
enzymes, including lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase 
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and acid phosphatase within the testis, indicating an increase in the metabolic activity of the  
testis, whereas Kasinathan et al. (338) reported that the concentration of PDE within the testis 
decreased by 20% following FBX, which suggests a biochemical link between the testis and FB 
where the FB directly supplies the testis with PDE.   
 The 20% reduction in the testicular concentration of PDE should effectively increase the 
testicular cAMP concentration, which, in turn, would upregulate expression of the StAR protein, 
ultimately leading to increased steroidogenesis (338).  As previously discussed, Kasinathan et al. 
(264) reported that FBX caused a highly significant reduction in testicular cholesterol levels (i.e., 
steroidogenic activity increased), which Kasinathan et al. (338) suggests is likely secondary to 
the reduction in PDE levels following FBX.  These findings provide strong evidence that the 
amphibian gonadal FB plays an important role in the local regulation of testicular function by a 
rapid, direct method and possibly via an indirect, slow (systemic) process (271, 338). 
 Past evidence suggests that gonadal WAT mediates reproductive function.  These 
findings to date raise the possibility that the gonadal WAT uniquely support spermatogenesis, 
possibly through the release of: i.) PGs, cAMP, growth factors or cytokines such as IL-1α and 
IL-1β, which influence Sertoli cell differentiation and steroidogenesis (10, 143-145, 146, 339-
341);  or  IL-6, which influences germ cell proliferation and testicular maturation (144, 342);  ii.)  
high-energy storage molecules, such as low-density lipoproteins, cholesterol,  or FFAs in 
response to a FMF/LMF of PD or hypothalamic origin (156, 343);  or iii.) some other previously 
unidentified adipokine (276, 277, 344, 345).  Alternatively, EWAT removal may incidentally 
damage the nerve supply of the testis or induce an autoimmune response within the epididymis, 
the latter effect accompanied by an increase in the concentration of pro-inflammatory cytokines 
within the epididymis followed by the recruitment and migration of immunologically competent 
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cells into the lumen of the epididymis.  Phagocytosis of the autoantigenic spermatozoa stored in 
the epididymis results in the subsequent production of anti-sperm antibodies by the naïve 
immune cells (346-349), an autoimmune condition, which has been previously linked to 
infertility in men (350-352). 
 Considering the anatomical relationship of the epididymis to the testis, an inflammatory 
response is free to spread to the testis via the contiguous network of vessels (Fig . 1), which are 
unobstructed in the healthy testis (63).  The subsequent destruction of the Sertoli cell blood-testis 
barrier by lymphocytes and the invasion of the germinal and epididymal lumina with antisperm 
antibodies produced in the epididymis and testicular (interstitial) macrophages has been shown to 
severely disrupt spermatogenesis following vasectomy (Vx) and/or vasectomy reversal by 
vasovasostomy (Vso) in rodents (46, 47, 346, 347, 349, 353-363),  rabbit (45, 364),  canine (363) 
and man (349, 365-370).   EWAT lipectomy, like vasectomy, might also impair testicular 
endocrinology and trigger apoptosis in the developing germ cells, which significantly reduces 
spermatogenic yield, leading to a pathophysiologic state of irreversible infertility (371, 372).  
Lastly, edema associated with EWATx-induced inflammation might increase intratesticular 
pressure and inhibit capsular contraction necessary to expel spermatozoa out of the testis (364, 
370, 373), which results in testicular atrophy (374-377), and consequently, reduces 
spermatogenic yield (363, 378, 379). 
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V. Overview of neutral control of white adipose tissue  
 The SNS controls the mobilization of lipids from WAT.  The earliest reports which 
describe the lipolytic influences of the nervous system on white fat date back nearly 100 years 
(380).  Mansfeld (380) reported that unilateral spinal cordotomy increased the accumulation of 
white fat in the paralyzed leg of canine ipsilateral to the cordotomy.  Unilateral denervation of 
the LSN, a sympathetic fiber, of several mammalian species increased the size of the ipsilateral 
fat pad, as compared to the LSN-intact contralateral (control) pad (for reviews see 381, 382-384).  
Weiss and Maickel (385) defined the physiological role of the SNS in adipose function in 
eloquent electrical nerve stimulation experiments.  The researchers reported that electrical 
stimulation of fibers innervating  the IWAT and EWAT of rat enhanced lipolysis, whereas the 
lipolytic effects of electrical stimulation was significantly reduced in rats pretreated with 
compounds which prevent the presynaptic packaging or release of NE and E and with other 
compounds that antagonize the α-ADR.  Treatment with 2,2'-dichlorobiphenyl (DCB), a 
selective β-ADR antagonist, completely blocked lipolysis induced by electrical nerve 
stimulation, while treatment with pargyline, a MAOI, and theophylline, which inhibits PDE, 
enhanced the lipolytic effects of electrical stimulation (385).   In summary, these studies 
demonstrate the central role of the SNS in mediating lipid mobilization (384), specifically 
through the α2-ADR, which when activated by the binding of NE, inhibits lipid mobilization,  
and the β1-3-ADRs, which when activated, promotes lipolysis.  
 Transynaptic retrograde axonal tracing using the pseudorabies virus (PRV) demonstrated 
the extensive SNS outflow from brain to WAT (386-388).  Youngstrom and Bartness (389) 
characterized the postganglionic sympathetic innervation of WAT using fluorescent retrograde 
and anterograde tract tracers.  Occasionally contacting individual adipocytes (2-3%), the 
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postganglionic, sympathetic fibers associate with the parenchyma, vasculature and innervate the 
major fat depots of most mammals, including humans (243) and rat (390).   Slavin indicated that 
the blood vessels through EWAT (except for veins and venules) are extensively innervated with 
adrenergic fibers down to the capillary bed of EWAT, more so than the vasculature of IWAT.  
Fredholm (391) observed gap-like junctions between adipocytes which could provide 
communication routes between innervated  and non-innervated adipocytes. 
 CNS modulates lipolysis via anterior hypothalamic inputs.  Our understanding of the 
central neural control adipocyte function was enhanced by novel studies involving 2-
deoxyglucose (2-DG), a competitive inhibitor to glucose.  Following 2-DG administration, an 
experimental animal experiences a compensatory increase in FFA mobilization and plasma 
glucose concentration (392-394).  Teixeira et al. (395) observed that administration of 2-DG 
reduced FFA serum concentration to subnormal levels in hypothalamic deafferentated rats, 
owning to a significant reduction in the mobilization of FFA from fat stores.  However, 2-DG 
elicited the normal/expected increase in plasma glucose levels in deafferentated animals (395).   
Conversely, the researchers observed a significant reduction in the 2-DG-induced increase in 
plasma glucose and FFAs levels in deafferentated and adrenodemedullated animals, whereas 
FFAs concentration was not significantly different in adrenodemedullated animals than in intact 
animals after 2-DG administration.  These results rule out significant adrenal medullary control 
of lipolysis ( i.e., through its release of NE and E), and suggest that CNS, via hypothalamic input 
to the SNS outflow to WAT, mediates lipid mobilization (384, 395). 
 Sensory innervation of WAT may serve to monitor energy reserves.  Evidence for the 
sensory innervation of WAT has been reviewed previously (see refs. 381, 383, 384).  Sensory 
innervation of white fat was first demonstrated by the injection of True Blue, an anterograde tract 
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tracer, into the IWAT and dorsal subcutaneous pads of rat, resulted in labeling of the neuronal 
cells in the dorsal root ganglion, whose afferents relay sensory information from the periphery 
into the CNS (381, 384).  Subsequent researchers reported that the IWAT and EWAT pads of 
Siberian hamster and laboratory rat were immunoreactive to substance P and CGRP, both 
neuropeptide neurotransmitters produced and secreted primarily from sensory fibers (381, 383).   
 Although the exact function of sensory innervation of WAT is unknown, it is speculated 
that the sensory innervation informs the CNS of the size of lipid stores, a function which is 
homologous to that of leptin and insulin (384).  Alternatively, the chemoreceptors of sensory 
neurons might also relay information regarding the lipolytic rate by measuring the primary 
products of lipolysis—FFAs and glycerol—the latter serving as a better lipolytic indicator since 
newly-liberated FFAs are unreliable indicators because these compounds are oftentimes returned 
immediately to adipocytes to be reesterified to TAG (384).  Sensory innervation might also 
mediate the perfusion rate to WAT via a feedback loop that regulates the vasomotor activity of 
the WAT vascular bed or the WAT afferents could synapse onto SNS centres within the CNS, 
thereby indirectly controlling the rate of lipolysis by innervating the sympathetic output to WAT 
(262, 384).   
 Parasympathetic drive to white fat.  The exact nature of the parasympathetic drive to 
white fat is controversial (243, 396, 397).  Kreier et al. (398) reported that injection of PRV into 
the sympathectomized retroperitoneal white adipose tissue (RWAT) of rats resulted in bilateral 
infection of the DMV, the chief nucleus of the PSNS.  Conversely, Giordano reported ―sparse‖ 
labeling of the DMV after bilateral injection of PRV into hamster IWAT (399).  Critics of 
parasympathetic innervation of white fat argue that there is a total absence of immunoreactivity 
to PSNS-specific markers (e.g., VIP, NOS, and vesicular acetylcholine transporter protein) in the 
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epididymal, inguinal, or retroperitoneal fat depots of rats after ICC assay (396, 399).  Moreover,  
Ballantyne (400) reported that acetylcholinesterase—an enzyme responsible for the breakdown 
of Ach— could not be detected in WAT, whereas Rosell and Belfrage (401) found little evidence 
of cholinergic innervation of WAT.  The injection of PRV into the IWAT of Siberian hamsters, 
previously treated with the catecholaminergic toxin 6-OHDA—which, in effect, spared the 
putative parasympathetics—did not result in viral infection of the sympathetic chain or CNS, 
whereas vehicle-injected controls showed classic sympathetic chain and CNS viral infection 
patterns—findings which provide strong evidence against significant parasympathetic 
innervation of WAT (396, 399).    
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VI. Specific aims of the present study  
   While beyond the scope of the present study, it is apparent that further investigation is 
warranted to effectively elucidate the functions of the WAT afferents as well as the exact nature 
of the autonomic innervation of WAT, which, concerning the latter problem, would definitively 
resolve the discrepant findings of the investigative groups led by Kreier and Giordano.  Despite 
the vagaries regarding neural control of WAT, the evidence presented in the preceding 
discussion raised several questions, most notably, does testicular innervation uniquely contribute 
to the maintenance of normal spermatogenesis, or alternatively, does EWAT alone play a role in 
this process?  The findings discussed here provide considerable evidence that the spermatogenic 
process, which has been shown to be partly under hormonal and autonomic neural control, could 
be disrupted by transection of the testicular nerves, namely the SSN and ISN, at the immediate 
surface of the testicular capsule, a hypothesis tested in the present study.  
 To dissociate the effects of nerve transection and EWAT lipectomy on spermatogenesis, 
three experimental groups (n = 6 males/group) of Syrian hamsters (Mesocricetus auratus) were 
created which received one of the following surgical treatments: i.) transection of the testicular 
nerves, most notably the SSN and ISN, which may course through EWAT en route to testes, ii.)  
surgical removal of EWAT, which may also denervate the testes, or iii.) sham testicular nerve 
transection and sham EWAT lipectomy.  In this report, the abbreviations SSNx, EWATx, and 
SHAM, respectively,  will be used to refer to these treatment groups.  
 Previous experiments suggest that EWAT lipectomy significantly reduced intratesticular 
NE content (unpublished data).  To ensure the success of the testicular denervation procedure 
and to characterize the anatomical arrangement of the nerves to the testis and EWAT, animals 
were assayed for NE content (testicular and EWAT) at autopsy using high-phase liquid 
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chromatography (HPLC).   Moreover, to assess the effects of our surgical treatments on 
spermatid development (i.e., spermiogenesis in this case) and seminal tubular  morphology 
among the three experimental groups, a spermatozoa maturity index was created, which was 
based on the observations of Russell et al. (2) and a modification of the techniques of Hess (56, 
58), to classify stages 10-19 of spermatogenesis.  Lastly, to test the hypothesis that EWAT 
lipectomy results in an inflammatory response (specifically, antisperm autoimmunity), which has 
been theorized to compromise testicular histology and spermatogenesis (353, 361, 362), 
testicular sections from each treatment group were subjected to ICC using the anti-mouse P84 
antibody (402, 403).  The P84 antibody is immunoreactive against the CD172a cell adhesion 
marker found on the surfaces of myeloid cells (i.e., all white blood cells, except lymphocytes) 
and macrophages, which are situated in the testicular interstitium under normal physiological 
conditions (70, 71, 404).  In accordance with the autoimmunity hypothesis, it was predicted that 
immune cell labeling should be distributed to the interstitial and luminal regions of the EWATx 
testis, but only to the interstitial regions of the SSNx or SHAM testes.   
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MATERIALS AND METHODS 
 
I. General experimental procedures 
 
 Animals.  Eighteen Syrian hamsters (2.5-3 months old), obtained from Harlan Sprague 
Dawley, were divided into three experimental groups (n= 6 hamsters/group), matched for body 
mass and percent body mass change, after a 1-2 week single-housing adaptation period.  The 
animals were weighed once per week and were housed at 20°C with lights on 14h per day (off 
from 12:30 pm to 10:30 pm EST).  All animals were supplied with ad libitum chow and tap 
water.  The Georgia State University Institutional Animal Care and Use Committee approved all 
experimental procedures in accordance with the Public Health Service and United States 
Department of Agriculture guidelines. 
 General surgical treatments.  Each experimental group received one of the following 
surgical treatments: i.) bilateral surgical transection of the testicular nerves, namely the SSN and 
ISN (SSNx, n = 6), ii.) bilateral removal of EWAT (EWATx, n = 6) or iii.) bilateral sham 
lipectomy and sham testicular nerve transection (SHAM, n = 6).  Hamsters were anesthetized 
with isoflurane  (2.0-4.0% isoflurane delivered in 100% oxygen) for all surgeries.  After initial 
anesthesia, continuous anesthesia was maintained using 1.0-3.0% isoflurane in 100% oxygen 
delivered by nosecone.  Hair was removed from the incision site and swabbed with a povidone-
iodine (PVPI) topical solution.  
 Following surgery, body mass and food intake was measured weekly to the nearest 0.01 g 
for 12 weeks, a time when compensation for lipectomy-induced lipid deficits is complete (405).   
At the end of 12 weeks, the animals were sacrificed by rapid decapitation, the fat pads and testes 
harvested, weighed and processed for histological verification. 
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 Testicular nerve transection and sham surgery.  A single median incision was made in 
the ventral abdomen, through which the testes and both EWAT pads were withdrawn from the 
peritoneal cavity, with blood vessels and nerves intact.   The testes and EWAT pads were kept 
moist by laying them on 0.15M NaCl-soaked gauze during the denervation procedure according 
to the method of Shi and Bartness (405).  The SSN was localized with the dissecting microscope, 
gently separated from the spermatic artery near the SL, and a section of approximately 1cm was 
carefully excised, according to a modification of the techniques of Kullendorff  (406).  The ISN 
was separated from the vas deferens near the IL using the dissecting microscope and a ~1cm 
section was excised (222, 406).  To ensure complete testicular denervation, nerves entering into 
the hilium at the posterior pole of the testis, as well as nerves embedded in the peritoneum 
(dorsal to the caput epididymis), were also transected (171, 222).  Sham surgery for each type of 
nerve transection was done exactly as described above, however, no testicular nerves were 
removed. 
 EWAT lipectomy and sham lipectomy.  In the EWATx group, the testes and EWAT pads 
were removed from the peritoneal cavity and kept moist by laying them on a NaCl-soaked gauze 
as described above for the denervation procedure.  The EWAT pads were dissected by severing 
them from the surrounding tissue and blood supply or were subjected to sham surgery, which 
involved all steps except the severing of the EWAT pads from the animal.  The EWAT pads 
were excised with care taken to avoid damage to the testicular blood supply, nerves or 
musculature, as previously described (407, 408).  The abdominal peritoneum was closed with 
sterile absorbable gut sutures and sterile wound clips were used to close the skin.  Nitrofurozone 
powder was applied to the incision site surface to decrease the incidence of infection (407, 408).   
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 Tissue harvesting, processing, and microscopic analysis.  Twelve weeks post-surgery, the 
animals were sacrificed by rapid decapitation.  The EWAT pads and testes from the SSNx and 
SHAM males were extirpated, along with the testes of the EWATx males.  The excised EWAT 
pads and one testis (randomly selected) from each animal were then weighed and frozen in liquid 
nitrogen at -80°C.  To verify successful nerve transection, the fat pads and testis were assayed 
(separately) for NE content using HPLC with electrochemical detection, which is described in 
Section IV.   
 The remaining testis from each male was weighed and submerged at room temperature 
(RT) into Bouin’s fixative mixed with 1% (vol/vol) dimethyl sulfoxide (DMSO).  The testes 
remained submerged for 24h and dehydrated in an ascending ethanol (EtOH) series to 100% 
EtOH with several changes of each concentration over a 10-day period until most of the fixative 
was removed.  Each testis was then cross sectioned into two parts and subjected to several 
washes in xylene solution over a 10-day period.  The testes was then immersed in several 
changes of liquid paraffin in a 64°C oven, embedded in paraffin blocks, cut into 5-8 µm thick 
sections, and mounted on slides.  The slides were stained with Harris haematoxylin and eosin (H 
& E), and cover-slipped.  In each animal, 30-40 seminal tubules were chosen at random and 
examined at a power of 800X.  Seminal tubules, which best characterized the experimental 
group, were photographed, and a histopathological (qualitative) assessment was completed for 
each experimental group. 
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II. Quantification of testicular histology and spermatogenesis 
 Seminal tubule thickness and sperm count measurements.  Randomly selected, non-
overlapping microscopic fields (n = 50 fields, each measuring 243 µm x 178µm) were viewed at 
a power of 800X  by an observer blind to the experimental treatments, and in each field, sperm 
were counted and epithelium thickness was measured in one seminiferous tubule.  Microscope 
field measurements were then averaged to yield the following dependent variables: i.) 
seminiferous tubule epithelial width (in microns) and ii.) number of spermatozoa per 
seminiferous tubule up to n = 50 sperm heads observed.  
 Proportion of sperm-positive tubules.  At a power of 800X, an observer blind to the 
experimental treatments examined adjacent, non-overlapping microscopic fields (n = 25 fields, 
each measuring  59 µm x 43µm), and in each field,  the observer examined randomly-selected 
seminiferous tubules (n = 25) for the presence of spermatozoa.  Microscopic field measurements 
from each testis were then averaged to yield a third dependent variable for each experimental 
group:  (iii.) Proportion of sperm-positive seminiferous tubules observed per randomly-selected 
seminiferous tubules (n = 25).   
 Sperm maturation index.   Concurrently, with the preceding measurement, randomly-
chosen, sperm-positive seminiferous tubules (n = 25) were assigned a numerical variable for the 
highest stage of spermiogenesis observed.  The aim of this measurement was to identify 
spermatids (and spermatozoa) in stages 10-19 (the upper spermatogenic stages), which were 
distinguished from stages 1-9 (the lower spermatogenic stages) by various morphological 
differences in the acrosomal (nuclear) head, flagellar status, and distribution of cytoplasm (2, 56, 
58, 68).  The acrosomal tip, which according to Russell (2), first appears during stage 10, was 
used to delimitate the upper stages from the lower stages.  Sperm classified into stages 10-11 had 
compressed nuclear heads with poorly-staining flagella, which, concerning the latter feature, was 
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considered a distinct feature of stages 10-11 of spermatogenesis (2).   Sperm classified into 
stages 12-14 were characterized by the polarization of the cytoplasm towards the base of the 
flagella (i.e., distal to the acrosome), whereas the curved acrosome, which was the most 
distinguishing feature of sperm in stages 15-17,  was fashioned into a ―pronounced hook‖ and the 
space immediately below the acrosome protruded into a conspicuous  ―ventral fin‖ (2).   Finally, 
the appearance of sickled-shaped acrosomal heads and loss of cytoplasmic volume indicated 
fully mature sperm, which were classified into stages 18-19.  Microscopic field measurements 
from each testis were averaged to yield a fourth dependent variable for each experimental group:  





III. ICC labeling of the CD172a cell adhesion molecule 
   Because the testicular sections were previously mounted and coverslipped, the ICC assay 
was performed directly on the glass slides, according to a technical modification of the method 
of Huddleston et al. (136). The slides were first soaked in xylene for 48h to remove the 
coverslips, thence rehydrated in 50% EtOH for 1h, followed by subsequent washes (5×15 min) in 
0.1M phosphate buffer (PB).  A ring of high vacuum [silicone] grease (Dow Corning Corp., 
Midland, MI) was applied to Field A, the section nearest the frosted side of each slide, to which 
was pipetted100 µl of the primary antibody—purified rat anti-mouse P84 (=CD172a) 
monoclonal antibody (diluted 1:1000; catalog no. 552371,  BD Biosciences, San Jose, CA; 
generously provided by Dr. Yuan Liu, Georgia State University)—which was solubilized in 
0.1M PB and 3% normal donkey serum (NDS; Jackson Laboratories, Bar Harbor, ME).  Field A 
was incubated at RT for 2h, after which the slides were transferred to 0.1M PB for 30 min., 
followed by addition of  100 µl of the secondary antibody— donkey anti-rat biotinylated 
antibody (diluted 1:200; catalog no. 712-065-150, lot 28689, Jackson Laboratories)—solubilized 
in 0.1M PB and 3% NDS for 2h at RT.  Slides were subsequently washed in 0.1M PB for 30 min 
and 100 µl of 1/10 strength avidin-biotinylated peroxidase complex (ABC; Vectastain Elite 
standard ABC peroxidase kit, Vector Laboratories, Burlingame, CA) solubilized in 0.1M PB, 
which was pipetted onto Field A.  Slides were rinsed in 0.1M PB for 20 min, followed by 
addition of  100 µl of 0.2M mg/ml diaminobenzidine (DAB; Sigma, St. Louis, MO) solubilized 
in  0.1 µl/ml of H2O2 and 0.1M PB.  The sections were incubated at RT for ~10 minutes before 
being transferred to 0.1M PB to end the DAB reaction, following by dehydration  in 90% EtOH  
for 30 minutes (136).  Finally, the slides were cleared in fresh xylene (which also removed the 
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silicone grease), re-coverslipped with a DPX mounting medium and allowed 48h to cure before 
the sections were viewed under lower power (250X) with the light microscope.    
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IV. Norepinephrine content assays and statistical analysis 
 HPLC norepinephrine (NE) content measures.  The norepinephrine tissue content was 
measured using reverse-phase, HPLC with electrochemical detection, following Youngstrom and 
Bartness’s (389) modification of the method of Mefford  et al. (409) as described recently (410).  
Briefly, tissue was thawed and homogenized in a solution containing dihydroxybenzylamine 
(DHBA, internal standard) in 0.2M perchloric acid (PCA) with 1mg/ml ascorbic acid (AA).  The 
amount of tissue processed and DHBA added was variable to obtain NE values within the range 
of the standards.  Following centrifugation for 15 min (7500x g at 5C), catecholamines were 
extracted from the homogenate with alumina and eluted into the PCA/AA. The catecholamines 
were assayed using an ESA Biosciences (Bedford, MA) HPLC system with electrochemical 
detection (Coulochem II). The mobile phase was Cat-A-Phase II, while the column was a HR-80 
reverse phase column. Testicular NE content was expressed as pictogram (pg)/testis, whereas NE 
content for both EWAT pads was averaged and reported in nanograms (ng). 
 Statistical analysis.  Comparisons between groups were analyzed by 1-way analysis of 
variance (ANOVA), followed by post hoc, pair-wise comparisons among means using the Fisher 
least significant differences (LSD) tests (411, 412).  In situations where ANOVA could not be 
employed, the Student’s  t test for independent samples was performed for between group 
comparisons.  Two-tailed probabilities are reported in all cases.  
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  RESULTS  
 
 
I. Microscopic analysis  
  Histopathologic findings.  All stages of spermatogenesis and in the cycle were observed 
in the seminiferous tubules of the SSNx and SHAM testes, which were abundant in sperm, 
whereas a majority of the seminal tubules in the EWATx testes were azoospermic, indicating 
that spermatogenic activity was severely disrupted within this group (Fig. 3).  The tubular 
epithelia of the latter two groups contained the full complement of germ cells (i.e., Type A and B 
spermatogonia, spermatocytes and spermatids), whereas these cells were either absent or 
degenerate (i.e., the nuclei were pyknotic and karyorrhexic) in the majority of epithelia in the 
EWATx testes.  Qualitative estimates suggested that the seminal lumina of the EWATx testes 
were greatly dilated, a histopathological feature not observed in the SSNx and SHAM testes.  
Moreover, the distribution of apoptotic cells and atrophied tubules in the EWATx testes was not 
uniform, but was spatially restricted to tubules in the center of the tissue section where it was 
apparent that contact between the Sertoli and germ cells had been lost resulting in disorganized 
cell associations and disruption in the stages of the cycle.  Seminal tubules along the periphery of 
the EWATx tissue section appeared healthy, had plentiful sperm and were indistinguishable from 
the seminal tubules of the SSNx and control testes.    
 In stark contrast to the SSNx and SHAM testes, the lumina of the EWATx testes were 
remarkable for irregular masses of seminal epithelium, which contained sloughed, elongated 
spermatids.  The spermatids were easily identified by their flagella which protruded from the 
center of the mass.  Numerous MGCs were observed within the seminal lumina of the EWATx 
testes, but not in the SSNx and SHAM testes.   
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II. Quantification of testicular histology and spermatogenesis 
 Seminal tubule thickness measurements.  Relative to hamsters in the SSNx (n = 4) and 
SHAM (n = 6) groups, in which the seminiferous tubular epithelium was thick and robust, the 
seminal epithelium in the EWATx (n = 5) group showed significant regression, specifically in 
seminiferous tubular epithelial thickness, yielding a significant difference among groups 
(F2,14=11.16, p < 0.002).  Follow-up, post hoc statistical comparisons revealed that the EWAT 
group had significantly reduced seminiferous tubule thickness compared to both the SSNx and 
the SHAM animals (p < 0.01), respectively (Fig. 4). The seminiferous tubule epithelial thickness 
in the EWAT-intact testes of the SSNx and SHAM groups did not differ significantly from each 
other.  
 Sperm count measurements. Sperm counts in the testes of the EWATx group were 
significantly lower compared with counts from the testes of the SSNx and SHAM animals 
(F2,14=14.52, p < 0.001).  The post-hoc group comparisons (Fig. 5) revealed that the sperm count 
in the EWAT-intact testes in the SSNx and SHAM groups did not differ significantly from each 
other, whereas EWATx hamsters had significantly lower sperm counts than either SSNx or 
SHAM groups (p < 0.01), respectively. 
 Proportion of sperm-positive tubules.  One-way ANOVA revealed that the proportions of 
sperm-positive seminiferous tubules (mean ± error) differed significantly between the three 
groups (F2,14 = 4.04, p < 0.046).  Follow-up, pair wise comparisons using Fisher LSD test (Fig. 
6)  revealed that the EWATx testes had significantly fewer sperm-positive seminiferous tubules 
than the SSNx and SHAM testes (p < 0.05, respectively), whereas the latter two groups did not 
differ significantly from each other (p = n.s., respectively).   
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 Sperm maturation index.   Group comparisons of sperm maturity revealed no significant 
difference in the level of sperm maturity among the three groups [Mean ± SEM:  SSNx; 23.5 ± 
1.19, EWATx; 20.80 ±1.66 and SHAM; 22.33 ±1.4], F2,14 = 0.76, p = n.s.   
 ICC labeling for the CD127a cell adhesion molecule.  Under low magnification (250X), 
the CD127a-ir pattern within the tissue sections of the SSNx group was somewhat varied.  While 
Cd127a-ir was distributed extensively to the interstitial, epithelial, and intraluminal regions of 
some SSNx sections, CD127a-ir labeling of the interstitial, epithelial and intraluminal regions of 
other SSNx sections was sparse and punctate at best.  The distribution of interstitial CD127a 
labeling on the EWATx sections was relatively sparse, while the pattern and distribution of 
epithelial and intraluminal CD127a labeling of EWATx sections closely resembled that of the 
SSNx sections.  CD127a-ir labeling on all regions on the SHAM sections was sparse and nearly 
absent in some cases.  In all cases—irrespective of the treatment group or intratesticular region— 
CD127a-ir labeling did not involve readily identifiable immune cells, but instead involved the 
labeling of non-descript particulate matter, a preliminary observation confirmed under high 
power (1000X).   
  HPLC norepinephrine content measures.  Group comparisons of testicular NE content 
indicated a significant difference among groups (F2,13 = 10.71, p < 0.003).  Follow-up, pair-wise 
group comparisons using the Fisher LSD test (Fig. 7) revealed that the testicular NE content of 
SSNx (n = 4) males was significantly lower (p < 0.05) than that of the EWATx (n = 5) and 
SHAM (n = 5) males, which did not differ significantly from each other (p < 0.05, respectively).  
Conversely,  t test analysis revealed that EWAT NE content in the SSNx males did not differ 
significantly from that of the SHAM controls (Fig. 8) [Mean ± SEM:  SSNx; 73.54 ± 18.26 and 






FIGURE 3: PHOTOMICROGRAPHS OF TESTICULAR SECTIONS (800X).  The various 
stages of spermatogenesis are visible in the healthy seminal tubule epithelia of the SSNx and 
SHAM  testes, whereas very little spermatogenic activity and severely atrophied seminiferous 






FIGURE 4: SEMINIFEROUS TUBULE THICKNESS.  Seminiferous tubule thickness (µm, 
mean ± error) in males that received EWAT lipectomy was significant smaller than that of males 
in the SSNx and SHAM groups, which did not different significantly from each other.  Asterisk 
(*) denotes significantly different from SHAM (p < 0.01). Dagger (†) denotes significantly 






FIGURE 5:  SPERM COUNT.  Sperm counts (mean ± error) in males that received EWAT 
lipectomy was significantly lower than that of males in the SSNx and SHAM groups, which did 
not differ significantly from each other.  Asterisk (*) denotes significantly different from SSNx 






FIGURE 6:  PROPORTION OF SPERM-POSITIVE SEMINIFEROUS TUBULES.  
Proportion of sperm-containing seminiferous tubules (mean ± error) in males that received 
EWAT lipectomy was significantly lower than that of the SSNx and SHAM groups, which did 
not differ significantly from each other.  Asterisk (*) denotes significantly different from SSNx 





FIGURE 7:  TESTICULAR NE CONTENT.  Testicular NE content (pg/testis, mean ± error) 
in males in the SSNx group was significantly lower than that of the EWATx and SHAM groups, 
which did not differ significantly from each other.  Asterisk (*) denotes significantly different 








FIGURE 8: EWAT NE CONTENT.  The EWAT NE content (ng, mean ± error) of the SSNx 





I. Major findings 
 EWAT removal results in morphological changes to the testis.  The presence of MGCs 
and the sloughing of epithelia and germ cells into the seminal lumen indicate widespread germ 
cell degeneration in the EWATx testis.  While it is not known what factors cause the spermatids 
to form MGCs instead of immediately degenerating (2),  there are numerous reports of testicular 
MGC formation after vasectomy (45, 361), epididymal obstruction (413),  and treatment with 
PGF2α (333) or with 6-OHDA (223).  Moreover, MGC formation increases with age and 
prolonged disease (29).  Although early studies provided strong evidence that vasectomy 
promoted the production of anti-spermatogenic antibodies within the epididymis, which 
purportedly impair the spermatogenic ability of the testis, the absence of intact immune cells in 
the seminal lumina of the EWATx testis and the lack of an observable difference in the CD127a-
ir labeling distribution between the treatment groups effectively rules out the hypothesis that 
EWAT lipectomy induces an inflammatory (autoimmune) response.  Alternatively, it is probable 
that lumicrine factors, which are secreted by the epididymal epithelium (or possibly the EWAT), 
may mediate germ cell development, a hypothesis which has not been tested.  In this way, 
considering that T, LH, and FSH secretion was relatively normal in the EWAT lipectomized, 
azoospermic males of an earlier study (unpublished data), the atrophy or total absence of the 
epididymis in the EWATx group might have impaired the secretion of epididymal factors, 
therefore compromising germ cell development.   
 Although Sertoli cells were present and still attached to the basal lamina, the intercellular 
associations between the Sertoli and developing germ cells were absent,  in addition to the 
compartmentalized microenvironments created by these associations which are critical for proper 
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germ cell development and viability (2).  Consequently, apoptotic pathways are triggered, 
followed by massive germ cell sloughing and loss of the morphological integrity of the germinal 
epithelium (27).  Russell warns that germ cell sloughing could also result from the mechanical 
stress of histological processing (2). Considering the excellent epithelial health and integrity of 
the SSNx and SHAM control testes as well as the absence of germ cell sloughing in these 
groups, the likelihood that mechanical stress caused the histopathologic effects observed in the 
EWATx testis is highly improbable. 
 Neural supply to testis and EWAT are independent.  The results of the NE content assays 
provide new insight on the neuroanatomical organization of EWAT and the testis.  First, the 
significantly reduced NE content of the SSNx testis confirms the success of the testicular 
denervation procedure.  Despite the SSNx testis having significantly reduced intratesticular NE 
content, as compared to SHAM and EWATx males, spermatogenesis was not impaired, 
suggesting that NE is not central in promoting spermatogenesis.  However, Mhauoty-Kodja 
demonstrated that NE (through its activation of the α1BADR) mediates Leydig and Sertoli cell 
function and spermatogenesis, making the role of NE in spermatogenic function somewhat more 
difficult to characterize (230).  Second, the intratesticular NE values of the EWATx testis, when 
compared to the SHAM control values, demonstrates that EWAT lipectomy does not disrupt 
autonomic input to the testis.  This finding, although inconsistent with the unpublished data of a 
previous study, demonstrates that the nerve supply to the testis and EWAT are independent (Fig. 
9).  An explanation for these discrepant findings is at hand.  In the present study, special care 
was taken in the removal of the EWAT, unlike in an earlier study (unpublished data), in which 
EWAT removal might have damaged the testicular nerves.  Thus, regarding the separate 
innervation of the testis and EWAT, we consider the present finding to be conclusive.  Whether 
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neural input to the EWAT is collateralized with that of the testis, completely separate, or a 
combination of these two possibilities cannot be definitively determined from the results of the 
NE content assays.  Third, the lack of a significant difference between the NE content of the 
EWAT pads of the SSNx and SHAM animals demonstrates that testicular nerve cuts do not 
compromise the sympathetic nerve supply to EWAT (Figures 8-9).  Lastly, in addition to the 
spermatic nerves, which innervate portions of the rat epididymis, it is likely that EWAT is also 
innervated by the mixed (sympathetic and afferent) hypogastric nerve, which, according to 







FIGURE 9:  NEUROANATOMICAL ORGANIZATION OF THE EWAT AND TESTIS.  
Neural supply to EWAT and testis are independent.  In Scenario , en passant innervation of 
EWAT and testis was hypothesized.  Thence, it was predicted, that EWAT lipectomy would 
effectively denervate the testis (as measured by testicular NE content), a finding which was not 
supported by the testicular NE content data of the EWATx testis.  Thus, Scenario  was ruled 
out.  In Scenario , innervation of EWAT and the testis are independent (i.e., collateralized or 
completely separate).  In this scenario, EWAT lipectomy would not disrupt testicular 
innervation, a prediction which was supported by the results of the NE assay.  Please see text for 
a complete explanation of the red X’s in Scenario .  
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II. Conclusions  
 EWAT, and not autonomic innervation, sustains spermatogenesis.  The lack of testicular 
pathology and the presence of sperm in the SSNx males effectively rule out a central role for 
testicular innervation in spermatogenesis, which is in stark contrast to earlier studies that 
reported significantly reduced spermatogenic ability and severe regression of the seminal tubule 
following surgical denervation of the testis (42, 43).  The results of this study are consistent with 
earlier experiments performed in our lab (unpublished data) and the observations of Srinivasan et 
al. (258), which demonstrate that EWAT lipectomy disrupts spermatogenesis and contributes to 
atrophy of the seminiferous tubules and epididymis.  Although hormonal RIA was not conducted 
in the present study,  gonadotrophin and sex hormone levels in EWATx males of an earlier study 
were relatively normal,  despite severe impairment to spermatogenesis and to the testicular 
histology (unpublished data).  Hence, it is concluded that the gonadal EWAT, alone, sustains 
normal spermatogenesis, and thus, the present data do not support the hypothesis that 
sympathetic innervation of the testis supports normal spermatogenesis.   
 Study Limitations.  Although outside the aims of the present study, the mechanism by 
which EWAT promotes spermatogenesis is perplexing to say the least.  The present study and 
earlier work in hamster (unpublished data),  Albino rat (258) and frog (271) provide strong 
evidence that the gonadal white fat is central to normal spermatogenesis and androgen 
production.  The studies in amphibians cited previously raise the possibility of novel a 
LMF/FMF secreted from the pituitary gland and/or hypothalamus (279), which, in addition to the 
sympathetic nervous system, mediates the mobilization of lipids and other nutritive factors from 
the EWAT.  Mobilization of the EWAT pad contents promotes the proliferation and 
development germ cells and Sertoli-Leydig cell function.  Moreover, the production and the 
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subsequent secretion of epididymal proteins into the testis could also mediate testicular function.  
In light of the themes presented by Kasinathan, Chieffi, and Hinton this explanation is highly 
plausible. 
  Alternatively, the seminal epithelial pathology and germ cell aberrations, which were 
observed in the EWATx testis only, could be the result of an inflammatory immune caused by 
the lipectomy procedure.  In the context of the literature reviewed here, the effects of 
inflammatory/immune response on testicular pathology is regarded as secondary to EWAT 
removal (i.e., the histopathologic features  observed in the EWATx testis were caused primarily 
by removal of EWAT and/or its nutritive factors, which may have been exaggerated by an 
immune response).  To elucidate how EWAT lipectomy contributes to testicular 
histopathogenesis, which may also involve temporally- and spatially-regulated events such as 
inflammation, longitudinal studies might be valuable, where the animals are sacrificed at 
consecutive, randomly-chosen time intervals, according to a modified method of Srinivasan 
(258).  Pro-inflammatory cytokines, such as IL-1α, which are expressed constitutively in the 
Sertoli cells of rat testis, mediate germ cell development and act as autocrine or paracrine factors 
to stimulate Sertoli cells growth and physiology to a greater degree than FSH, however,  the 
cytokines may exert negative effects on testicular function in prolonged diseased states (10, 143).  
Disruptions to physiological tissue remolding caused by increased production of IL-1 (and thus, 
increased expression of TIMP-1) in prolonged pathologic states such as inflammation (141),  
might have severely compromised the maintenance of the seminal epithelium  during stages in 
the cycle and reduced the spermatogenetic yield.  It is noted, however, that TIMP-1 levels were 
not measured in any of the three groups, so this explanation is merely speculative.   
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 Despite the EWATx testis having significantly reduced sperm counts and 30% less 
sperm-positive tubules than the SSNx and SHAM groups, sperm maturity measurements 
revealed no significant differences in the level of sperm maturity between the three groups.  
Thus, sperm, when present, were able to reach full maturity in the EWATx testis.  In light of the 
profound pathology observed in the EWATx testis, this finding is considered to be tentative and 
most likely the result of the unevenly distributed pathology in the EWATx testis, a phenomenon 
which was observed in the amphibian testis following removal of the gonadal fat bodies (265).   
A power analysis performed by Hess et al. (58) advises that a minimal of:  i.) n = 12 animals per 
experimental group and ii.) n = 200 seminiferous tubule cross sections should be observed to 
detect a difference of two standard deviations from the mean with a 2% error rate when 
classifying the stages in the cycle of the seminiferous tubules.  Owing to loss of sample, the 
average group size for the sperm maturity measurement was n = 5, whereas n = 25 seminiferous 
tubules were observed.  Thus, due to the pathologic changes in the EWATx testis, which were 
restricted to the center of the tissue section, and the group size number, the sperm maturity tool 
was underpowered and insensitive, failing to effectively reveal statistical variations in sperm 
maturity among the treatment groups.  
 The sequelae of the EWAT lipectomy procedure, which is remarkable for testicular 
lesions and disruptions to the spermatogenetic ability of the EWATx animal, may have far-
reaching clinical significance for the treatment of male infertility.  The present findings are 
consistent with a tentative interpretation that the EWAT supplies a trophic factor which sustains 
normal testicular physiology.  Thus, isolation of the putative trophic factor might yield an 
effective pharmacologic therapy for the treatment of male infertility, whereas selective agonists 
against the receptor for this trophic factor might also provide an effective target for enhancing 
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male productive capacity.  Conversely, antagonists directed against the same receptor might 
possibly provide an effective male contraceptive, while gene expression studies on EWATx, 
SSNx, and SHAMx animals may lead to advances in the treatment of male infertility via novel 
molecular/genetic approaches.  Although surgical vasectomy has traditionally been the widely 
preferred method of sterilization, blockade of the putative EWAT trophic factors might provide 
an alternative route for reversible sterilization.   
 In light of the recent reports regarding neural control of white fat, it is likely that neural 
input to EWAT promotes lipid mobilization and/or the secretion of the trophic factors, which in 
turn, support spermatogenesis and testicular function. Whereas earlier workers reported 
spermatogenic defects, severe regression of the seminiferous tubules following SCI (182, 185, 
194), chemical (35, 223-225),  surgical denervation at more distal locations [e.g., at the spinal 
autonomic outflow (164) and near the pampiniform plexus of the spermatic cord (42, 43, 197, 
198)], it is emphasized here that transection of the nerves in the present study was performed at 
the immediate testicular surface.  In this way, all nerves entering the testis were denervated, 
while the nerves serving the epididymis, EWAT, and vas deferens were spared.  Considering the 
neuroanatomical organization of the EWAT and testis, which is theorized here, it is hypothesized 
that the nerve cuts performed by earlier workers incidentally denervated the EWAT, which, in 
effect, disabled the sympathetic drive necessary for lipid mobilization.  Therefore, it is predicted 
that axotomy of the nerves leading into the EWAT (see red X’s in Fig. 9) would likely impair the 
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